5-aminosalicylic acid

RX_A07EC02

No definition available.

Endpoint definition

↥

Endpoint definition steps	FinnGen
Phenotype data	520210
1. Apply sex-specific rule None	520210
2. Check conditions None	520210
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Medicine purchases: ATC — A07EC02 1 out of 7 registries used, show all original rules.	10673
4. Check minimum number of events Min. number of events 3	10673
5. Include endpoints None	10673
6. Filter based on genotype QC (FinnGen only)	10673

Control definitions (FinnGen only)

Control exclude: IBD_DRUGS

Extra metadata

First used in FinnGen datafreeze: DF4

NAME	RX_A07EC02
CONTROL_EXCLUDE	IBD_DRUGS
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10
HD_ICD_9
HD_ICD_8
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10
COD_ICD_9
COD_ICD_8
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC	A07EC02
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to 5-aminosalicylic acid based on the number of shared cases.

Similar with more cases:

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

Not enough data for upset plot.

Full data table

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	10673	5683	4990
Unadjusted period prevalence (%)	2.06	1.94	2.20
Median age at first event (years)	41.02	38.64	43.74

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

Not a core endpoint, no data to show.

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
9587: Matched controls
95865

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

208

Kela drug reimbursment

Ulcerative colitis and Crohn's disease

5846.0

323.0

8268

114

UJF45

NOMESCO Finland

Flexible sigmoidoscopy with biopsy

10.2

323.0

2210

2746

A07EA02

ATC

hydrocortisone; rectal

323.0

3106

142

UJF32

NOMESCO Finland

Coloscopy

19.9

323.0

6832

10621

K51

ICD-10 Finland

Ulcerative colitis

468.0

323.0

1198

A07EC01

ATC

sulfasalazine; oral, rectal

44.9

323.0

2037

572

K52.88

ICD-10 Finland

Other specified noninfective gastroenteritis and colitis

23.8

323.0

794

362

A06AC01

ATC

ispaghula (psylla seeds); oral

2.9

323.0

2657

11143

K50.0

ICD-10 Finland

Crohn disease of small intestine

120.6

323.0

1249

119

L04AB04

ATC

adalimumab; parenteral

83.8

323.0

641

O99.6

ICD-10 Finland

Diseases of the digestive system complicating pregnancy, childbirth and the puerperium

63.6

323.0

552

K50.1

ICD-10 Finland

Crohn disease of large intestine

490.3

323.0

1538

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

5.3

323.0

4132

12013

K51.3

ICD-10 Finland

Ulcerative (chronic) rectosigmoiditis

1612.5

323.0

2923

326

Kela drug reimbursment

Adalimumab, golimumab, infliximab and ustekinumab (intestinal diseases)

1322.1

323.0

845

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

3.4

323.0

3401

13213

UJF92

NOMESCO Finland

Capsular endoscopy

13.7

323.0

580

448

UJF14

NOMESCO Finland

Enteroscopy of ileoanal anastomosis

120.8

323.0

482

UJF30

NOMESCO Finland

Ileoscopy through colon

19.4

323.0

3775

3098

ZX120

NOMESCO Finland

Intravenous

5.5

323.0

1508

3162

A07EC02

ATC

mesalazine; oral, rectal

+∞

323.0

9587

358

L01BB02

ATC

mercaptopurine; oral

445.8

323.0

1006

K51.1

ICD-10 Finland

Ulcerative (chronic) ileocolitis

914.4

323.0

1341

D94

ICPC

Chronic enteritis/ulcerative colitis

221.6

323.0

699

K50.9

ICD-10 Finland

Crohn disease, unspecified

206.5

323.0

1616

K51.0

ICD-10 Finland

Ulcerative (chronic) pancolitis

444.3

323.0

1003

K50.8

ICD-10 Finland

Other Crohn disease

321.4

323.0

1760

202

Kela drug reimbursment

Connective tissue diseases, rheumatoid arthritis and comparable disease

7.4

323.0

1008

1493

K51.5

ICD-10 Finland

Left sided colitis

897.5

323.0

4547

M07.5*K51.9

ICD-10 Finland

Arthropathy in ulcerative colitis

834.0

323.0

323

P01AB01

ATC

metronidazole; oral, rectal

3.0

323.0

4721

23436

K51.9

ICD-10 Finland

Ulcerative colitis, unspecified

397.7

323.0

4469

210

A07EA01

ATC

prednisolone; rectal

345.0

323.0

608

H02AB07

ATC

prednisone; oral

9.7

323.0

2829

3977

K51.2

ICD-10 Finland

Ulcerative (chronic) proctitis

319.9

323.0

2002

J01MA02

ATC

ciprofloxacin; systemic

3.2

323.0

4514

21108

A07EA06

ATC

budesonide; oral, local oral

301.5

323.0

3614

192

H02AB06

ATC

prednisolone; systemic

12.1

323.0

7220

19252

L04AX01

ATC

azathioprine; systemic

879.7

323.0

3783

K52.9

ICD-10 Finland

Noninfective gastroenteritis and colitis, unspecified

15.6

323.0

1287

943

L04AX03

ATC

methotrexate; systemic (immunosuppressants)

8.9

323.0

972

1206

K51.8

ICD-10 Finland

Other ulcerative colitis

462.6

323.0

1883

A02BC02

ATC

pantoprazole; systemic

2.3

318.8

6043

40880

4AA12

NOMESCO Finland

400.3

311.8

312

K50

ICD-10 Finland

Crohn disease [regional enteritis]

192.8

304.7

317

4AB02

NOMESCO Finland

436.7

298.8

298

GD1AA

NOMESCO Finland

Thorax X-ray examination

2.3

297.8

3848

21418

C10AC01

ATC

colestyramine; oral

10.5

295.1

601

607

L01BA01

ATC

methotrexate; systemic (folic acid analog.)

45.0

286.2

356

JF1CG

NOMESCO Finland

Extensive MRI of small bowel

44.9

282.1

351

WX002

NOMESCO Finland

Sedation and analgesia

2.8

274.7

2126

8867

A07EC03

ATC

olsalazine; oral

690.1

273.4

269

TPH04

NOMESCO Finland

Cathetrisation of vein

2.7

264.5

2230

9763

K83.0

ICD-10 Finland

Cholangitis

18.0

264.3

422

244

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

2.8

259.0

2050

8626

56310

ICD-8 Finland

Chronic enteritis and ulcerative colitis, Ulcerative colitis

84.0

253.0

285

JFH30

NOMESCO Finland

Total colectomy, mucosal proctectomy and ileoanal anastomosis without ileostomy

204.7

249.9

259

5561A

ICD-9 Finland

Idiopathic proctocolitis, Ulcerative (chronic) ileocolitis

153.4

239.9

254

UJF12

NOMESCO Finland

Enteroscopy through intestinal stoma

67.7

216.5

251

NK6QA

NOMESCO Finland

Measurement of bone density from tow or more locations with X-ray

5.1

214.6

732

1540

5562A

ICD-9 Finland

Idiopathic proctocolitis, Ulcerative (chronic) proctitis

136.1

211.3

226

A07DA03

ATC

loperamide; oral

6.2

201.3

576

981

A05AA02

ATC

ursodeoxycholic acid; oral

9.7

197.5

417

446

5568X

ICD-9 Finland

Idiopathic proctocolitis, Other ulcerative colitis

150.3

194.3

206

L04AD01

ATC

ciclosporin; systemic

13.7

193.1

343

258

JF1DG

NOMESCO Finland

Small bowel very extensive MRI with with high intensity magnet

60.3

189.9

224

H02AB04

ATC

methylprednisolone; systemic

2.8

178.8

1288

5004

M07.4*K50.9

ICD-10 Finland

Arthropathy in Crohn's disease [regional enteritis]

448.4

177.5

177

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

3.2

176.2

1022

3432

JN3BD

NOMESCO Finland

Extensive abdominal CT

2.9

175.1

1173

4347

C05AA08

ATC

fluocortolone; rectal, topical

2.5

171.2

1508

6576

JFG00

NOMESCO Finland

Closure of loop enterostomy without resection

28.2

169.2

234

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

1.9

168.1

3372

21164

JKE98

NOMESCO Finland

Other transduodenal endoscopic operation on bile duct or ampulla of Vater

10.6

162.0

326

318

JN3AA

NOMESCO Finland

Abdominal X-ray examination without contrast

4.6

160.2

593

1351

L04AC05

ATC

ustekinumab; parenteral

63.2

158.9

186

JF1BD

NOMESCO Finland

Very extensive small bowel CT

29.4

153.6

210

A02BC03

ATC

lansoprazole; oral

2.0

151.0

2489

14389

L04AB06

ATC

golimumab; parenteral

81.5

148.8

168

N02AX02

ATC

tramadol; systemic, rectal

1.8

143.9

3506

23200

1370

FHL

Colonoscopy, whole colon

30.3

142.4

193

A02BC01

ATC

omeprazole; systemic

2.0

142.3

2325

13340

H02AB09

ATC

hydrocortisone; systemic

7.7

140.7

340

454

NK4XE

NOMESCO Finland

Joint ultrasound examination not elsewhere classified

4.5

137.0

514

1184

K56.6

ICD-10 Finland

Other and unspecified intestinal obstruction

5.5

136.2

423

792

K62.8

ICD-10 Finland

Other specified diseases of anus and rectum

13.0

134.6

244

192

3042

Kela drug reimbursment

+∞

131.5

126

253

Kela drug reimbursment

+∞

131.5

126

JFA15

NOMESCO Finland

Endoscopic polypectomy in colon

4.1

131.4

541

1362

M45

ICD-10 Finland

Ankylosing spondylitis

10.5

130.3

262

255

A02BC05

ATC

esomeprazole; systemic

1.8

128.7

3399

22852

4AA33

NOMESCO Finland

1265.2

128.4

125

M07.5

ICD-10 Finland

Arthropathy in ulcerative colitis

+∞

128.4

123

N02BE01

ATC

paracetamol; systemic, rectal

1.8

126.9

7674

65774

WX302

NOMESCO Finland

Thoracal epidural anesthesy

3.6

126.7

611

1765

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

2.4

122.6

1216

5567

K62.5

ICD-10 Finland

Haemorrhage of anus and rectum

3.6

122.4

589

1697

JFH33

NOMESCO Finland

Total colectomy, mucosal proctectomy, ileoanal anastomosis and ileostomy

399.1

118.9

119

K92.1

ICD-10 Finland

Melaena

3.9

118.4

527

1421

313

Kela drug reimbursment

Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab, tocilizumab and ustekinumab (rheumatoid diseases)

14.8

114.5

196

135

A04.7

ICD-10 Finland

Enterocolitis due to Clostridium difficile

6.3

112.0

310

502

3005

Kela drug reimbursment

Tofacitinib

169.1

111.5

117

281

Kela drug reimbursment

Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab and tocilizumab

15.0

111.2

189

128

Z01.8

ICD-10 Finland

Other specified special examinations

1.9

110.9

1864

10661

K57.3

ICD-10 Finland

Diverticular disease of large intestine without perforation or abscess

2.2

107.5

1288

6417

Z93.2

ICD-10 Finland

Ileostomy status

26.5

106.4

149

3AC01

NOMESCO Finland

11.0

106.1

208

193

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

2.2

105.3

1166

5600

J01MA12

ATC

levofloxacin; systemic

2.1

104.5

1438

7592

A03CA02

ATC

clidinium and psycholeptics; oral

3.4

104.2

553

1717

L04AA01

ATC

[U] ciclosporin; systemic

13.9

102.5

180

132

JFH11

NOMESCO Finland

Laparoscopic colectomy

1009.2

102.4

100

TNX10

NOMESCO Finland

Arthrocentesis, unspecified region, unspecified region

3.9

100.9

447

1198

A07AA09

ATC

vancomycin; oral

10.4

100.7

203

199

601

Kela drug reimbursment

Severe malabsorption of nutrients, mainly fats

11.1

100.5

196

180

JFH10

NOMESCO Finland

Total colectomy and ileostomy

32.6

99.5

132

JJ2AT

NOMESCO Finland

Biopsy of liver with ultrasound guidance

5.6

99.0

304

561

5552A

ICD-9 Finland

Regional enteritis, Small intestine with large intestine

206.1

98.6

102

K59.1

ICD-10 Finland

Functional diarrhoea

3.3

97.4

521

1626

JFH20

NOMESCO Finland

Proctocolectomy and ileostomy

117.9

97.1

105

Z2221

NOMESCO Finland

Medical doctor

1.7

96.5

2478

16189

L88

ICPC

Rheumatoid/seropositive arthritis

8.1

96.3

225

285

JFA98

NOMESCO Finland

Other transluminal endoscopic local operation on intestine

6.0

93.9

272

467

5560A

ICD-9 Finland

Idiopathic proctocolitis, Ulcerative (chronic) enterocolitis

125.0

92.1

N02AJ06

ATC

codeine and paracetamol; systemic

1.6

90.8

3176

22524

R50.9

ICD-10 Finland

Fever, unspecified

2.1

90.4

1201

6215

L04AA29

ATC

tofacitinib; oral

122.5

90.1

WX408

NOMESCO Finland

General anesthesy, balanced

1.7

89.9

2266

14668

JGB50

NOMESCO Finland

Mucosal proctectomy and ileoanal anastomosis

232.1

89.6

5550A

ICD-9 Finland

Regional enteritis, Small intestine

301.7

87.9

M05BA04

ATC

alendronic acid; oral

3.2

87.6

492

1590

56300

ICD-8 Finland

Chronic enteritis and ulcerative colitis, Regional enteritis

77.0

87.3

JN1CG

NOMESCO Finland

Extensive MRI examination of upper part of abdomen with high intensity magnet

4.5

85.2

316

717

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

1.5

81.9

3838

29030

P01BA02

ATC

hydroxychloroquine; oral

3.5

81.0

410

1225

J01DB01

ATC

cefalexin; oral

1.6

80.8

7331

64351

ZXE00

NOMESCO Finland

One hour or less

1.6

80.5

3345

24564

D50.9

ICD-10 Finland

Iron deficiency anaemia, unspecified

2.7

80.4

603

2348

JFA58

NOMESCO Finland

Endoscopic dilatation of colon

34.2

80.2

105

K51.4

ICD-10 Finland

Inflammatory polyps

395.7

79.0

JH1CG

NOMESCO Finland

Extensive MRI of perianal area

12.8

78.9

143

113

JFF10

NOMESCO Finland

Loop enterostomy

13.1

78.6

141

109

E0000UV

ATC

1.5

77.2

3246

23843

J45.9

ICD-10 Finland

Asthma, unspecified

2.0

77.1

1129

6048

A02BA02

ATC

ranitidine; systemic

1.8

77.0

1420

8272

JFB00

NOMESCO Finland

Partial resection of small intestine

6.1

76.1

216

362

JL5BG

NOMESCO Finland

MRI examinaiton of bile and pancreas ducts with high intesity magnet

4.5

75.9

285

655

A06AC51

ATC

ispaghula, combinations; systemic

2.9

74.4

473

1661

K60.3

ICD-10 Finland

Anal fistula

4.7

74.0

262

567

JFB20

NOMESCO Finland

Ileocaecal resection

13.3

73.5

131

100

5551A

ICD-9 Finland

Regional enteritis, Large intestine

+∞

73.0

B03BA03

ATC

hydroxocobalamin; parenteral

3.0

72.3

451

1564

J01FA10

ATC

azithromycin; systemic

1.5

71.8

5148

42240

ZY020

NOMESCO Finland

Telephone, letter or other consultation without direct patient contact

2.6

71.5

573

2315

WVA20

NOMESCO Finland

Medicine administration

4.4

70.9

268

620

ZXD10

NOMESCO Finland

Scheduled procedure

1.5

70.8

3062

22517

M07.4

ICD-10 Finland

Arthropathy in Crohn disease [regional enteritis]

354.9

70.7

B01AB05

ATC

enoxaparin; parenteral

1.6

69.8

2185

14842

UJF02

NOMESCO Finland

Peroral enteroscopy

11.4

69.6

133

118

JHA00

NOMESCO Finland

Anal or perianal incision

5.3

69.5

219

417

JN3AD

NOMESCO Finland

Abdominal CT examination

2.4

68.8

632

2747

L04AA33

ATC

vedolizumab; parenteral

+∞

68.8

JF1AD

NOMESCO Finland

Small bowel CT

14.7

68.0

116

K56.5

ICD-10 Finland

Intestinal adhesions [bands] with obstruction

5.4

67.8

212

400

JN1DG

NOMESCO Finland

Very extensive MRI examination of upper part of abdomen with high intensity magnet

5.0

67.5

226

461

203

Kela drug reimbursment

Chronic asthma and similar chronic obstructive pulmonary diseases

1.8

67.4

1209

6949

D07AC01

ATC

betamethasone; topical

1.5

67.2

2639

18929

R03DC03

ATC

montelukast; oral

1.9

66.9

1086

6027

L30.9

ICD-10 Finland

Dermatitis, unspecified

1.8

65.7

1385

8387

D11

ICPC

Diarrhoea

1.9

65.6

1052

5813

M13.9

ICD-10 Finland

Arthritis, unspecified

2.7

64.7

479

1847

JL5AG

NOMESCO Finland

Simple MRI examinaiton of bile and pancreas ducts with high intesity magnet

8.8

64.0

141

163

NA6BG

NOMESCO Finland

Sacro-iliac joint MRI examination with high intensity magnet

5.9

63.8

186

323

JL5SB

NOMESCO Finland

Endoscopic retrograd cholangiopancreaticography

5.7

63.4

190

341

D16

ICPC

Rectal bleeding

4.3

63.4

246

584

K61.0

ICD-10 Finland

Anal abscess

4.6

63.0

230

514

M09.2*K51.9

ICD-10 Finland

Juvenile arthritis in ulcerative colitis

+∞

62.6

JFA38

NOMESCO Finland

Endoscopic dilatation of small intestine

110.8

60.9

UJG02

NOMESCO Finland

Proctoscopy

4.1

60.8

248

617

R01AD08

ATC

fluticasone; nasal

1.5

60.8

2292

16210

ZXE20

NOMESCO Finland

More than three and less than five hours

1.8

59.7

1051

5985

H20.0

ICD-10 Finland

Acute and subacute iridocyclitis

3.1

58.9

338

1108

R03AC02

ATC

salbutamol; inhalant

1.4

58.7

4138

33285

K56.7

ICD-10 Finland

Ileus, unspecified

5.3

57.8

183

351

J01AA02

ATC

doxycycline; systemic

1.4

57.5

6420

56156

UJF34

NOMESCO Finland

Left colonoscopy

9.1

57.4

123

136

Z71.3

ICD-10 Finland

Dietary counselling and surveillance

2.6

57.1

455

1830

5586X

ICD-9 Finland

Other non-infective gastro-enteritis and colitis[KROONINEN INFLAMMATOORINEN SUOLISTOSAIRAUS, NUD]

197.8

57.1

UJK12

NOMESCO Finland

Peroral cholangioscopy

21.7

56.9

M05.8

ICD-10 Finland

Other seropositive rheumatoid arthritis

5.0

56.6

188

381

WX404

NOMESCO Finland

Intravenous generell anesthesy

1.6

56.4

1657

10984

R03BB04

ATC

tiotropium bromide; inhalant

2.5

55.8

467

1930

TQX10

NOMESCO Finland

Biopsy of skin and subcutaneous tissue

2.1

55.7

658

3211

UJD02

NOMESCO Finland

Gastroscopy

2.7

55.3

401

1529

ZXE10

NOMESCO Finland

More than one and less than three hours

1.5

54.9

2743

20542

K58.0

ICD-10 Finland

Irritable bowel syndrome with diarrhoea

2.4

54.5

501

2173

J02AC01

ATC

fluconazole; systemic

1.4

54.4

3152

24306

Z3231

NOMESCO Finland

Registered nurse

1.5

53.5

2082

14758

J01EE01

ATC

sulfamethoxazole and trimethoprim; systemic

2.4

53.4

477

2038

J01FA06

ATC

roxithromycin; oral

1.4

52.9

3078

23717

A49.9

ICD-10 Finland

Bacterial infection, unspecified

2.0

52.2

678

3441

JX1LA

NOMESCO Finland

Kinetic X-ray of alimentary tract with pictures

26.8

52.0

WX402

NOMESCO Finland

General anaesthesia

1.6

51.8

1368

8794

D12.6

ICD-10 Finland

Benign neoplasm: Colon, unspecified

2.7

51.4

373

1422

A07AA02

ATC

nystatin; oral

2.5

51.2

424

1742

R03AK06

ATC

salmeterol and fluticasone; inhalant

1.9

50.1

789

4311

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

2.0

49.8

687

3568

D06BX01

ATC

metronidazole; topical

1.9

49.7

823

4577

E000001

ATC

1.6

49.6

1593

10763

R01AD09

ATC

mometasone; nasal

1.4

49.3

3685

29629

J18.9

ICD-10 Finland

Pneumonia, unspecified

1.6

48.9

1405

9226

K21.0

ICD-10 Finland

Gastro-oesophageal reflux disease with oesophagitis

1.9

48.7

725

3874

D07AC13

ATC

mometasone; topical

1.5

48.7

2190

15963

UJK02

NOMESCO Finland

ERCP

3.6

48.5

227

638

M35.3

ICD-10 Finland

Polymyalgia rheumatica

6.1

48.5

136

226

TJF80

NOMESCO Finland

Ostomy education

5.9

47.8

138

238

UJF30

SPAT

10.4

47.3

JF1AB

NOMESCO Finland

Passage examination of small bowell with X-ray

5.0

47.3

158

323

R01AD12

ATC

fluticasone furoate; nasal

1.4

47.2

2450

18371

UJH02

NOMESCO Finland

Anoscopy

2.6

46.9

365

1450

JFG20

NOMESCO Finland

Closure of enterostomy with resection of exteriorised loop

10.4

46.8

WX602

NOMESCO Finland

Repeated or continuing anesthesia shots throug a catheter

1.9

46.7

761

4201

N03AX16

ATC

pregabalin; oral

1.5

46.7

1633

11244

J01DA01

ATC

[U] cefalexin; systemic

1.4

46.5

5200

44581

K76.9

ICD-10 Finland

Liver disease, unspecified

5.1

46.3

151

301

JAH00

NOMESCO Finland

Laparotomy

3.3

46.1

245

761

K44.9

ICD-10 Finland

Diaphragmatic hernia without obstruction or gangrene

2.1

45.5

524

2524

R19.8

ICD-10 Finland

Other specified symptoms and signs involving the digestive system and abdomen

4.9

45.2

152

313

5559X

ICD-9 Finland

Regional enteritis, Unspecified site

231.0

45.0

TJJ00

NOMESCO Finland

Percutaneous needle biopsy of liver

16.0

44.6

ZXD05

NOMESCO Finland

Urgent procedure

1.4

44.0

2455

18622

S01XA20

ATC

artificial tears and other indifferent preparations; ophthalmic

1.4

43.3

2714

21015

WW200

NOMESCO Finland

Immunization

3.0

43.2

266

913

1490

FHL

Sigmoideoscopy (fiberscope)

13.7

43.1

R03AK07

ATC

formoterol and budesonide; inhalant

1.6

43.0

1319

8780

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.4

42.8

3289

26381

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

1.8

42.5

771

4415

D18

ICPC

Change in faeces/bowel movements

3.6

42.3

200

568

D07AB02

ATC

hydrocortisone butyrate; topical

1.4

42.2

2099

15546

DM1QA

NOMESCO Finland

Paranasal sinuses X-ray examination in one projection

2.6

42.0

316

1229

K73.2

ICD-10 Finland

Chronic active hepatitis, not elsewhere classified

24.7

41.8

C05AA01

ATC

hydrocortisone; rectal, topical

2.3

41.6

421

1912

DM1AA

NOMESCO Finland

Paranasal sinuses X-ray examination without contrast

3.0

41.5

254

871

JFG40

NOMESCO Finland

Revision of enterostomy or colostomy without laparotomy

13.4

41.5

J01CA04

ATC

amoxicillin; systemic

1.4

41.4

7152

65131

JFG73

NOMESCO Finland

Excision of ileal pelvic pouch

210.9

40.9

JFB33

NOMESCO Finland

Other resection comprising small intestine and colon

26.8

40.6

JFF13

NOMESCO Finland

Terminal enterostomy

16.8

40.6

B81

ICPC

Anaemia vit B12/folate deficiency

2.9

40.4

262

933

ND2DA

NOMESCO Finland

Bilateral hand X-ray examination

5.4

39.5

121

225

M25.5

ICD-10 Finland

Pain in joint

1.4

39.4

2089

15626

XX6XT

NOMESCO Finland

Other intravascular therapy with radiological guidance

14.8

39.2

D50.0

ICD-10 Finland

Iron deficiency anaemia secondary to blood loss (chronic)

2.9

39.2

246

859

M46.9

ICD-10 Finland

Inflammatory spondylopathy, unspecified

7.7

39.1

120

K43.9

ICD-10 Finland

Other and unspecified ventral hernia without obstruction or gangrene

2.4

38.6

331

1383

M01AH01

ATC

celecoxib; oral (coxibs)

1.6

38.6

1163

7691

107

Kela drug reimbursment

Pernicious anaemia

4.0

38.5

160

407

D07AD01

ATC

clobetasol; topical

1.6

38.2

1077

7002

R06AE07

ATC

cetirizine; oral

1.3

38.1

3422

27994

JGB40

NOMESCO Finland

Excision of rectum and end ileostomy

378.9

38.0

SPAT1256

SPAT

Intramuscular and subcutaneous injection

1.4

38.0

3039

24404

DMB20

NOMESCO Finland

Functional endoscopic opening of maxillary antrum

2.3

38.0

370

1651

J05AB11

ATC

valaciclovir; oral

1.6

38.0

958

6049

M46.1

ICD-10 Finland

Sacroiliitis, not elsewhere classified

5.2

37.8

119

229

JF1DM

NOMESCO Finland

Very extensive MRI of small bowel (more than 1.5 T)

102.9

37.7

J32.0

ICD-10 Finland

Chronic maxillary sinusitis

2.0

37.6

512

2643

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

2.0

37.6

491

2494

J05AB01

ATC

aciclovir; systemic

1.5

37.5

1532

10860

Z98.0

ICD-10 Finland

Intestinal bypass and anastomosis status

8.8

37.3

E27.3

ICD-10 Finland

Drug-induced adrenocortical insufficiency

27.0

37.1

A01AB09

ATC

miconazole; local oral

1.9

36.9

568

3068

K92.2

ICD-10 Finland

Gastrointestinal haemorrhage, unspecified

3.1

36.9

212

697

56902

ICD-8 Finland

Other diseases of intestines and peritoneum, Proctitis haemorrhagica (ulcerosa)

36.3

36.8

J01EE02

ATC

sulfadiazine and trimethoprim; systemic

1.4

36.8

2135

16214

N06AX11

ATC

mirtazapine; oral

1.4

36.6

2357

18231

6403

FHL

Ileocal resection

49.1

36.6

L04AA13

ATC

leflunomide; oral

8.4

36.4

JF1CM

NOMESCO Finland

Small bowel extensive MRI with with high intensity magnet

54.0

36.3

N05CF01

ATC

zopiclone; oral

1.4

36.3

2174

16594

J06.9

ICD-10 Finland

Acute upper respiratory infection, unspecified

1.3

36.1

3725

31044

K55.9

ICD-10 Finland

Vascular disorder of intestine, unspecified

15.1

36.0

JHD30

NOMESCO Finland

Incomplete incision of fistula-in-ano

11.9

35.7

WZC00

NOMESCO Finland

Planning of intervention or health care consultation

1.4

35.5

2522

19812

J45.1

ICD-10 Finland

Nonallergic asthma

2.2

35.4

379

1768

NF1AE

NOMESCO Finland

Hip joint ultrasound examination

3.9

35.2

149

386

L88

ICD-10 Finland

Pyoderma gangrenosum

40.2

35.2

Z94.4

ICD-10 Finland

Liver transplant status

12.1

35.0

J01MA14

ATC

moxifloxacin; systemic

1.9

35.0

528

2832

D01

ICPC

Abdominal pain/cramps general

1.7

34.9

822

5088

Z93

ICD-10 Finland

Artificial opening status

9.5

34.3

K21.9

ICD-10 Finland

Gastro-oesophageal reflux disease without oesophagitis

1.8

34.2

671

3931

R03BA02

ATC

budesonide; inhalant

1.5

33.8

1141

7740

M03BC51

ATC

orphenadrine, combinations; systemic

1.4

33.7

2130

16379

R06.0

ICD-10 Finland

Dyspnoea

1.5

33.5

1478

10626

R03BA05

ATC

fluticasone; inhalant

1.5

33.5

1183

8109

1300

FHL

Esophagogastroduodenoscopy (also includes staining)

5.4

33.4

103

194

D01AC20

ATC

imidazoles/triazoles in combination with corticosteroids; topical

1.4

33.3

1621

11876

M81.4

ICD-10 Finland

Drug-induced osteoporosis

25.7

33.1

JF2AB

NOMESCO Finland

Colongraphy with X-ray

11.1

33.1

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

1.5

32.8

1115

7572

J45.0

ICD-10 Finland

Predominantly allergic asthma

1.9

32.7

517

2818

J45

ICD-10 Finland

Asthma

1.9

32.6

535

2955

R03BA01

ATC

beclometasone; inhalant

1.6

32.5

855

5446

E86

ICD-10 Finland

Volume depletion

3.3

32.3

166

505

R10.1

ICD-10 Finland

Pain localized to upper abdomen

1.5

32.2

1137

7784

TPH15

NOMESCO Finland

Insertion of central venous catheter through external or internal jugular vein

2.1

32.0

398

1978

J01FA09

ATC

clarithromycin; systemic

1.4

31.9

2364

18642

L01BB01

ATC

165.5

31.7

M03BX02

ATC

tizanidine; oral

1.3

31.7

5103

44932

0093A

ICD-9 Finland

Ill-defined intestinal infections, Diarrhoea of presumed infectious origin

3.7

31.6

141

383

J46

ICD-10 Finland

Status asthmaticus

4.6

31.6

112

246

R03AC03

ATC

terbutaline; inhalant

1.6

31.3

907

5920

TPH20

NOMESCO Finland

Insertion of central venous catheter through subclavian or brachiocephalic vein

2.8

31.3

208

754

D64.9

ICD-10 Finland

Anaemia, unspecified

1.8

31.3

563

3206

SPAT1131

SPAT

Colonoscopy

2.6

31.2

236

925

D07XC01

ATC

betamethasone, combinations; topical

1.6

31.0

802

5087

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

1.3

31.0

4082

34955

XJW99

NOMESCO Finland

Other investigative procedure on digestive system

9.7

30.9

WZC30

NOMESCO Finland

Teaching

1.6

30.8

853

5502

SPAT1263

SPAT

Sampling

1.3

30.8

3239

26884

TDM10

NOMESCO Finland

Puncture of maxillary antrum

2.4

30.8

265

1112

I84.2

ICD-10 Finland

Internal hemorrhoids without complication

1.8

30.5

540

3057

M09.1*K50.9

ICD-10 Finland

Juvenile arthritis in Crohn's disease [regional enteritis]

303.3

29.8

R03AC13

ATC

formoterol; inhalant

2.5

29.8

247

1018

SPAT1255

SPAT

Intravenous administration of medicine

2.0

29.6

414

2159

M06.0

ICD-10 Finland

Seronegative rheumatoid arthritis

5.3

29.5

172

ZX112

NOMESCO Finland

Subcutaneous

3.1

29.4

164

530

M02AA07

ATC

piroxicam; topical

1.3

29.4

2433

19462

R10.3

ICD-10 Finland

Pain localized to other parts of lower abdomen

1.4

29.4

1628

12188

D07BB04

ATC

hydrocortisone butyrate and antiseptics; topical

1.6

29.4

919

6109

A03BA03

ATC

hyoscyamine; oral

5.3

29.2

170

1380

FHL

Colonoscopy, left side

24.2

29.1

NH3DA

NOMESCO Finland

Bilateral foot X-ray examination

4.0

29.1

118

296

R03AC12

ATC

salmeterol; inhalant

2.7

29.0

199

736

JFG50

NOMESCO Finland

Laparotomy with revision of enterostomy or colostomy

31.8

29.0

M06.9

ICD-10 Finland

Rheumatoid arthritis, unspecified

4.5

29.0

104

232

FB1BD

NOMESCO Finland

Extensive CT examination of arteria pulmonalis

1.9

28.9

453

2462

K83.8

ICD-10 Finland

Other specified diseases of biliary tract

13.6

28.9

K29.3

ICD-10 Finland

Chronic superficial gastritis

2.6

28.5

213

829

JHD20

NOMESCO Finland

Incision of fistula-in-ano

4.0

28.5

115

287

D07AB08

ATC

desonide; topical

1.6

28.5

719

4527

N06AA09

ATC

amitriptyline; systemic

1.7

28.3

593

3541

D99

ICPC

Disease digestive system other

4.4

28.3

104

238

N02AA05

ATC

oxycodone; systemic

1.6

28.2

770

4944

R01BA52

ATC

pseudoephedrine, combinations; oral

1.3

28.2

2193

17358

56399

ICD-8 Finland

Chronic enteritis and ulcerative colitis, Other

18.8

28.2

L04AB01

ATC

etanercept; parenteral

10.1

28.0

WZB00

NOMESCO Finland

Telephone receipt or other advice

1.3

28.0

2244

17841

UGC12

NOMESCO Finland

Flexible bronchoscopy

2.0

27.9

384

1990

R96

ICPC

Asthma

1.9

27.8

436

2368

J01.0

ICD-10 Finland

Acute maxillary sinusitis

1.4

27.8

1579

11863

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

1.7

27.8

555

3268

M05.9

ICD-10 Finland

Seropositive rheumatoid arthritis, unspecified

7.6

27.6

S18

ICPC

Laceration/cut

1.3

27.6

2882

23803

Z03.89

ICD-10 Finland

Observation for other suspected diseases and conditions

1.6

27.6

854

5664

K56.0

ICD-10 Finland

Paralytic ileus

4.8

27.5

195

Z01.5

ICD-10 Finland

Diagnostic skin and sensitization tests

1.7

27.5

648

4000

D12.3

ICD-10 Finland

Benign neoplasm: Transverse colon

3.0

27.5

164

554

K52.80

ICD-10 Finland

(Hemorrhagic) colitis caused by antibiotics

10.7

27.4

DNB20

NOMESCO Finland

Endoscopic ethmoidectomy

2.9

27.4

167

575

JHD33

NOMESCO Finland

Completing incision of fistula-in-ano

9.5

27.3

TGC00

NOMESCO Finland

Bronchial lavation

3.4

27.2

136

407

SPAT1325

SPAT

Vaccination

1.3

27.1

2230

17784

4AC05

NOMESCO Finland

+∞

27.1

Z3226

NOMESCO Finland

Physiotherapist

1.4

26.9

1241

8962

JHB30

NOMESCO Finland

Rubber band ligature of haemorrhoids or prolapse of mucosa

1.9

26.7

401

2147

JHD00

NOMESCO Finland

Anal dilatation

4.5

26.6

211

SPAT1262

SPAT

Handing over of treatment supplies

1.5

26.5

1155

8249

J01FF01

ATC

clindamycin; systemic

1.3

26.4

1900

14835

K91.4

ICD-10 Finland

Colostomy and enterostomy malfunction

11.4

26.3

JFB21

NOMESCO Finland

Laparoscopic ileocaecal resection

16.2

26.2

ZXC86

NOMESCO Finland

Use of endoscopic device

5.9

26.1

127

GD1ED

NOMESCO Finland

Extensive high resolution CT examination of lungs

3.1

26.1

145

469

J15.9

ICD-10 Finland

Bacterial pneumonia, unspecified

1.8

25.9

450

2533

J44.0

ICD-10 Finland

Chronic obstructive pulmonary disease with acute lower respiratory infection

3.0

25.9

156

533

M01AH02

ATC

rofecoxib; oral

1.6

25.8

764

5008

R03DA04

ATC

theophylline; systemic, rectal

2.5

25.7

212

872

JJC00

NOMESCO Finland

Allogenic transplantation of liver

12.5

25.7

R06AX27

ATC

desloratadine; oral

1.3

25.5

2067

16427

M79.0

ICD-10 Finland

Rheumatism, unspecified

2.5

25.4

197

784

JHW96

NOMESCO Finland

Other operation on anus or perianal tissue

6.5

25.3

102

H04.10

ICD-10 Finland

Dry eye syndrome

1.7

25.2

599

3705

J44.8

ICD-10 Finland

Other specified chronic obstructive pulmonary disease

1.9

25.2

397

2163

J01FA15

ATC

telithromycin; oral

1.6

25.1

672

4292

N06CA01

ATC

amitriptyline and psycholeptics; systemic

1.6

25.1

621

3883

Y83

ICD-10 Finland

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1.8

24.9

463

2664

WX110

NOMESCO Finland

Local anesthesy

1.3

24.9

5838

53052

ICD-10 Finland

2.7

24.7

177

673

M80.4

ICD-10 Finland

Drug-induced osteoporosis with pathological fracture

21.2

24.7

B02.9

ICD-10 Finland

Zoster without complication

2.0

24.7

325

1656

J01DA09

ATC

[U] cefadroxil; inhalant, oral

1.3

24.5

2031

16175

R03AK08

ATC

formoterol and beclometasone; inhalant

2.6

24.4

179

691

C03CA01

ATC

furosemide; systemic

1.4

24.3

1289

9541

UKC02

NOMESCO Finland

Cystoscopy

1.5

24.3

909

6280

R11

ICD-10 Finland

Nausea and vomiting

1.7

24.3

529

3195

K76.0

ICD-10 Finland

Fatty (change of) liver, not elsewhere classified

2.5

24.1

197

806

K52.0

ICD-10 Finland

Gastroenteritis and colitis due to radiation

10.7

24.0

XF400

NOMESCO Finland

ECG with 12 standard connections

1.5

24.0

983

6927

K75.9

ICD-10 Finland

Inflammatory liver disease, unspecified

4.0

23.9

240

K61.1

ICD-10 Finland

Rectal abscess

7.8

23.9

A03FA01

ATC

metoclopramide; systemic, rectal

1.4

23.8

1313

9784

S01CA01

ATC

dexamethasone and antiinfectives; ophthalmic (ophth., corticosteroids and antiinfectives in comb.)

1.3

23.7

2079

16682

N06AX21

ATC

duloxetine; oral

1.6

23.7

712

4679

GD1DD

NOMESCO Finland

High resolution CT examination of lungs

2.3

23.7

227

1008

R51.80

ICD-10 Finland

Headache

1.4

23.7

1048

7499

NA6AA

NOMESCO Finland

Sacro-iliac joint X-ray examination

9.6

23.6

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

1.4

23.5

1194

8769

RD210

NOMESCO Finland

2.8

23.4

156

568

JH1CM

NOMESCO Finland

Perianal extensive MRI with 3 Tesla magnet

21.3

23.4

M81.9

ICD-10 Finland

Osteoporosis, unspecified

2.5

23.3

183

735

R03AK10

ATC

vilanterol and fluticasone furoate; inhalant

2.3

23.1

215

941

E000002

ATC

1.5

23.0

793

5381

JAD30

NOMESCO Finland

Repair of incisional hernia using prosthetic material

3.1

23.0

128

416

JL5CG

NOMESCO Finland

Extensive MRI examinaiton of bile and pancreas ducts with high intesity magnet

4.2

22.9

207

QBB10

NOMESCO Finland

Major dressing of wound of skin of trunk

2.1

22.8

262

1264

D07CA01

ATC

hydrocortisone and antibiotics; topical

1.5

22.6

905

6341

5761C

ICD-9 Finland

Other disorders of biliary tract, Cholangitis[CHOLANGITIS SCLEROSIVA]

120.3

22.6

N05CF02

ATC

zolpidem; oral

1.4

22.5

1241

9240

D07BC01

ATC

betamethasone and antiseptics; topical

1.5

22.5

798

5449

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

1.4

22.3

1010

7250

UJF32

SPAT

2.9

22.3

137

476

K29.7

ICD-10 Finland

Gastritis, unspecified

2.2

22.3

221

999

A02BA04

ATC

nizatidine; systemic

1.7

22.2

448

2645

A02BA03

ATC

famotidine; systemic

2.2

22.1

227

1041

NH3EA

NOMESCO Finland

Feet X-ray examination with load

3.3

22.1

115

356

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

1.6

22.1

635

4128

K83.9

ICD-10 Finland

Disease of biliary tract, unspecified

7.3

22.1

M01AX17

ATC

nimesulide; oral

1.3

21.6

1477

11401

SPAT1083

SPAT

Initiation and monitoring of IV fluid therapy

2.1

21.5

259

1273

H20.1

ICD-10 Finland

Chronic iridocyclitis

4.4

21.5

182

D07AA02

ATC

hydrocortisone; topical

1.4

21.5

972

6974

R4110

NOMESCO Finland

Physiotherapy

1.3

21.5

1759

13946

OAB74

NOMESCO Finland

Nutritional guidance related to treatment and rehabilitation for medical condition

4.5

21.5

169

J01MA01

ATC

ofloxacin; systemic

1.6

21.4

517

3211

SPAT1148

SPAT

Treatment of chronic ulcer or burn

1.5

21.4

743

5052

R91

ICD-10 Finland

Abnormal findings on diagnostic imaging of lung

1.7

21.3

459

2764

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

1.5

21.2

757

5173

R01AD58

ATC

fluticasone, combinations; inhalant, nasal

1.3

21.2

1534

11942

UDH02

NOMESCO Finland

Rhinopharyngoscopy

1.8

21.2

397

2292

T81.8

ICD-10 Finland

Other complications of procedures, not elsewhere classified

2.7

21.1

147

551

JAP00

NOMESCO Finland

Freeing of adhesions in the peritoneal cavity

3.7

21.1

253

TPH07

NOMESCO Finland

Cathetrisation of artery

1.6

21.1

607

3946

J32.4

ICD-10 Finland

Chronic pansinusitis

4.1

21.0

205

S01BA01

ATC

dexamethasone; ophthalmic (corticosteroids, plain)

2.1

20.9

234

1117

XG410

NOMESCO Finland

Flow-volume spirometry

2.2

20.9

209

950

A02BX02

ATC

sucralfate; oral

2.1

20.8

242

1172

M79.6

ICD-10 Finland

Pain in limb

1.3

20.8

2420

20108

JJ9AE

NOMESCO Finland

Ultrasound examination of liver transplant

14.8

20.6

H26.3

ICD-10 Finland

Drug-induced cataract

6.9

20.6

B04AD01

ATC

15.8

20.5

J44.1

ICD-10 Finland

Chronic obstructive pulmonary disease with acute exacerbation, unspecified

3.6

20.5

265

XG412

NOMESCO Finland

Flow-volume spirometry with bronchospasmolysis

1.9

20.4

304

1626

E000006

ATC

1.7

20.4

444

2681

TNH11

NOMESCO Finland

Injection of diagnostic or therapeutic substance in ankle joint or foot joint

8.2

20.3

NA6CG

NOMESCO Finland

Sacro-iliac joint extensive MRI examination with high intensity magnet

5.9

20.1

R2130

NOMESCO Finland

Counselling and guidance which enhance independent living

1.6

20.1

494

3085

WW500

NOMESCO Finland

Blood transfusion

2.1

20.1

239

1170

WX892

NOMESCO Finland

Monitored bed care

1.7

20.1

449

2733

R06AE09

ATC

levocetirizine; oral

1.4

20.0

1009

7388

L04AA06

ATC

mycophenolic acid; systemic

3.3

20.0

100

302

K30

ICD-10 Finland

Functional dyspepsia

1.5

19.9

673

4545

L40.0

ICD-10 Finland

Psoriasis vulgaris

1.9

19.9

275

1431

N03AX12

ATC

gabapentin; oral

1.4

19.9

935

6759

J01AA04

ATC

lymecycline; systemic

1.4

19.9

995

7277

Y0599

ICD-8 Finland

Investigation of digestive system

2.9

19.8

120

412

D12.8

ICD-10 Finland

Benign neoplasm: Rectum

2.1

19.8

228

1105

XQ800

NOMESCO Finland

Prick test

1.6

19.7

488

3054

A01AB04

ATC

amphotericin B; local oral

2.0

19.6

256

1302

JN3CD

NOMESCO Finland

Abdominal CT examination both without and with contrast

2.2

19.6

209

976

ND2AA

NOMESCO Finland

Hand and fingers X-ray examination

1.6

19.6

505

3195

R05FA02

ATC

opium derivatives and expectorants; systemic

1.2

19.5

2882

24600

M01CB01

ATC

sodium aurothiomalate; parenteral

9.3

19.5

SPAT1249

SPAT

Treatment-related counselling outside office

1.2

19.4

2879

24579

JN1BG

NOMESCO Finland

MRI examination of upper part of abodmen with high intensity magnet

3.9

19.4

211

S01BA04

ATC

prednisolone; ophthalmic (corticosteroids, plain)

2.7

19.4

136

512

NA3BG

NOMESCO Finland

Lumbar spine MRI examination with high intensity magnet

1.5

19.4

595

3929

A98

ICPC

Health maint/preventive medicine

1.5

19.3

8951

86882

A02BC04

ATC

rabeprazole; oral

1.6

19.3

550

3569

K73.9

ICD-10 Finland

Chronic hepatitis, unspecified

9.1

19.3

ZXE30

NOMESCO Finland

More than five and less than seven hours

1.8

19.2

317

1756

A03FA02

ATC

cisapride; oral, rectal

1.7

19.1

428

2606

JG1JB

NOMESCO Finland

Defekography with X-ray

4.7

19.0

140

K74.3

ICD-10 Finland

Primary biliary cirrhosis

5.5

18.9

103

Z01.0

ICD-10 Finland

Examination of eyes and vision

1.4

18.8

1039

7727

J33.8

ICD-10 Finland

Other polyp of sinus

2.8

18.8

119

422

I84.9

ICD-10 Finland

Unspecified hemorrhoids without complication

1.8

18.7

315

1759

M54.5

ICD-10 Finland

Low back pain

1.3

18.7

2339

19561

6419

FHL

Other measure in this category

11.0

18.6

TND11

NOMESCO Finland

Injection of diagnostic or therapeutic substance in joint, wrist or hand

5.7

18.6

S97

ICPC

Chronic ulcer skin

1.9

18.6

271

1439

B01AB10

ATC

tinzaparin; parenteral

1.7

18.6

406

2456

R01AD01

ATC

beclometasone; nasal

1.4

18.6

1003

7432

ZXX01

NOMESCO Finland

Extent of proceudre, 1 unit

5.1

18.5

114

M01AB55

ATC

diclofenac, combinations; oral

1.7

18.5

355

2066

M54.9

ICD-10 Finland

Dorsalgia, unspecified

1.5

18.5

712

4945

JFH00

NOMESCO Finland

Total colectomy and ileorectal anastomosis

8.4

18.3

J01MA06

ATC

norfloxacin; oral

1.4

18.3

828

5937

C07AB07

ATC

bisoprolol; oral

1.2

18.3

2727

23261

D12.5

ICD-10 Finland

Benign neoplasm: Sigmoid colon

2.0

18.3

226

1128

J33.0

ICD-10 Finland

Polyp of nasal cavity

2.4

18.3

157

664

D07BA04

ATC

hydrocortisone and antiseptics; topical

1.5

18.0

704

4907

TJD00

NOMESCO Finland

Insertion of nasogastric or naso-gastroduodenal tube

3.0

17.9

101

334

R03BA08

ATC

ciclesonide; inhalant

1.6

17.9

453

2852

R07.4

ICD-10 Finland

Chest pain, unspecified

1.3

17.9

1625

13037

L52

ICD-10 Finland

Erythema nodosum

4.3

17.8

155

R06AX13

ATC

loratadine; oral

1.4

17.8

1082

8177

L04AB05

ATC

certolizumab pegol; parenteral

26.7

17.8

J31.0

ICD-10 Finland

Chronic rhinitis

1.6

17.8

490

3156

JGB61

NOMESCO Finland

Laparoscopic excision of rectum and ileoanal anastomosis

+∞

17.7

SAA03

NOMESCO Finland

Extended examination of mouth

1.2

17.7

3054

26450

R03AK11

ATC

formoterol and fluticasone; inhalant

2.6

17.6

130

507

D12.2

ICD-10 Finland

Benign neoplasm: Ascending colon

2.3

17.6

167

743

N05BA04

ATC

oxazepam; oral

1.3

17.5

1665

13436

UDQ12

NOMESCO Finland

Flexible laryngoscopy

1.8

17.5

324

1864

R06AX22

ATC

ebastine; oral

1.3

17.5

1164

8922

7200A

ICD-9 Finland

Ankylosing spondylitis and other inflammatory spondylopathies, Ankylosing spondylitis

11.5

17.4

D12.0

ICD-10 Finland

Benign neoplasm: Caecum

2.5

17.2

135

546

C10AC02

ATC

colestipol; oral

6.7

17.2

M06.8

ICD-10 Finland

Other specified rheumatoid arthritis

10.3

17.1

JKE32

NOMESCO Finland

Endoscopic dilatation of bile duct

6.9

17.1

N05BA01

ATC

diazepam; systemic, rectal

1.4

17.0

826

5999

JFB96

NOMESCO Finland

Other partial excision of intestine

21.9

16.8

R4190

NOMESCO Finland

Nutritional therapy

1.9

16.8

236

1238

R05

ICD-10 Finland

Cough

1.3

16.8

1172

9044

R02

ICPC

Shortness of breath/dyspnoea

1.5

16.8

636

4404

Z35.8

ICD-10 Finland

Supervision of other high-risk pregnancies

1.5

16.8

559

3765

K90.0

ICD-10 Finland

Coeliac disease

2.0

16.7

209

1048

R74.0

ICD-10 Finland

Elevation of levels of transaminase and lactic acid dehydrogenase [LDH]

2.5

16.7

130

522

6402

FHL

Small bowel resection

10.4

16.6

K29.5

ICD-10 Finland

Chronic gastritis, unspecified

2.3

16.6

154

678

R03BB01

ATC

ipratropium bromide; inhalant

2.3

16.6

154

678

D29

ICPC

Digestive symptom/complaint other

2.4

16.5

137

570

B07.9

ICD-10 Finland

Verruca simplex

1.9

16.5

237

1252

M02AA10

ATC

ketoprofen; topical

1.4

16.5

973

7310

DM1AI

NOMESCO Finland

Cone beam CT of paranasal sinus

2.3

16.5

148

641

N17.9

ICD-10 Finland

Acute renal failure, unspecified

2.1

16.5

182

867

B80

ICPC

Iron deficiency anaemia

2.5

16.5

133

546

M02.9

ICD-10 Finland

Reactive arthropathy, unspecified

3.1

16.5

303

SPAT1153

SPAT

Removal of sutures

1.3

16.4

2028

16889

J84.9

ICD-10 Finland

Interstitial pulmonary disease, unspecified

3.4

16.4

233

M01AX01

ATC

nabumetone; oral

1.9

16.4

232

1219

K91.2

ICD-10 Finland

Postsurgical malabsorption, not elsewhere classified

9.5

16.3

R05DA20

ATC

opium alkaloids and derivatives - combinations

1.3

16.3

1746

14291

J01AA07

ATC

tetracycline; systemic

1.3

16.3

1150

8889

R53

ICD-10 Finland

Malaise and fatigue

1.3

16.2

1299

10229

R03AL09

ATC

formoterol, glycopyrronium bromide and beclometasone; inhalant

4.0

16.2

160

Z2446

NOMESCO Finland

Social worker

1.6

16.2

416

2632

K59.9

ICD-10 Finland

Functional intestinal disorder, unspecified

2.9

16.2

100

352

WX004

NOMESCO Finland

Patient-controlled sedation

4.7

16.1

115

K83.1

ICD-10 Finland

Obstruction of bile duct

3.2

16.0

270

NH3AA

NOMESCO Finland

Foot and toes X-ray examination

1.6

16.0

444

2863

JKE02

NOMESCO Finland

Transduodenal endoscopic incision of common bile duct orifice

2.9

16.0

342

L02.3

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle of buttock

2.2

15.9

161

738

R35

ICD-10 Finland

Polyuria

1.7

15.9

354

2155

B01AA03

ATC

warfarin; systemic

1.4

15.8

926

6950

M05BA07

ATC

risedronic acid; oral

2.5

15.8

121

482

N11.9

ICD-10 Finland

Chronic tubulo-interstitial nephritis, unspecified

7.1

15.7

5563A

ICD-9 Finland

Idiopathic proctocolitis, Ulcerative (chronic) proctosigmoiditis

60.1

15.7

M07.3*L40.5

ICD-10 Finland

Other psoriatic arthropathies

2.8

15.7

347

N11.8

ICD-10 Finland

Other chronic tubulo-interstitial nephritis

11.2

15.7

D50.8

ICD-10 Finland

Other iron deficiency anaemias

2.9

15.7

342

N06AX16

ATC

venlafaxine; oral

1.4

15.6

961

7268

WZC20

NOMESCO Finland

Multidisciplinary treatment meeting

1.7

15.6

314

1856

SAA02

NOMESCO Finland

Basic examination of mouth

1.2

15.6

5439

50178

I80.3

ICD-10 Finland

Phlebitis and thrombophlebitis of lower extremities, unspecified

2.0

15.5

204

1042

Z43.2

ICD-10 Finland

Attention to ileostomy

7.8

15.5

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

1.4

15.5

802

5891

R01AD05

ATC

budesonide; nasal

1.5

15.5

474

3130

K25.9

ICD-10 Finland

Gastric ulcer, Unspecified as acute or chronic, without haemorrhage or perforation

2.7

15.5

106

398

R03AK03

ATC

[D] fenoterol & other drugs for obstructive airway dis; inhalant

2.0

15.5

200

1019

127

Kela drug reimbursment

Transplant complication

2.9

15.4

333

H22.1*M45

ICD-10 Finland

Iridocyclitis in ankylosing spondylitis

38.1

15.4

JJ5AT

NOMESCO Finland

14.7

15.3

K85

ICD-10 Finland

Acute pancreatitis

2.5

15.2

119

481

R05

ICPC

Cough

1.3

15.2

1434

11536

K52.1

ICD-10 Finland

Toxic gastroenteritis and colitis

16.0

15.2

K62.4

ICD-10 Finland

Stenosis of anus and rectum

6.7

15.2

-44

ICPC

Preventive immunization/medic

1.5

15.2

467

3089

ZJX00

NOMESCO Finland

Double balloon technique in gastroenterological endoscopy

10.4

15.2

WD315

NOMESCO Finland

Multiple therapy of methastized malignancy with biomodifiers

8.7

15.1

6451

FHL

Dilatation

3.8

15.1

166

M01AE01

ATC

ibuprofen; systemic, rectal

0.8

15.1

7385

77183

S01GX01

ATC

cromoglicic acid; ophthalmic

1.3

15.1

1376

11019

JFB30

NOMESCO Finland

Right hemicolectomy

3.0

15.1

299

J45.8

ICD-10 Finland

Mixed asthma

2.3

15.1

133

573

JHA20

NOMESCO Finland

Excision of lesion of anal canal or perianal tissue

3.0

15.0

288

K60.2

ICD-10 Finland

Anal fissure, unspecified

2.4

14.9

126

530

D07CC01

ATC

betamethasone and antibiotics; topical

1.4

14.9

819

6077

Z98.8

ICD-10 Finland

LabWAS

↥

(ID) Name

N Cases

N Controls

-log₁₀(p)

cases

controls

unit

cases

controls

-log₁₀(p)

N cases

N controls

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

4156

23774

2.23

307.65

3.9

2.4

u/l

60.1

57.7

1.06

3918

22002

(36305075) Vedolizumab [Mass/volume] in Serum or Plasma by Immunoassay

393

814.48

307.65

3.2

2.2

mg/l

23.0

17.6

—

371

(36304052) Adalimumab Ab [Units/volume] in Serum or Plasma

380

106.45

307.65

2.1

1.5

au/ml

87.6

267.3

—

(3017181) Myelocytes/100 leukocytes in Blood

2162

5004

5.16

307.65

6.0

3.5

0.7

1.0

2.84

551

1261

(3007566) Smooth muscle Ab [Titer] in Serum

1063

2028

5.71

307.65

1.8

1.2

titre

74.7

107.2

0.91

110

179

(3037522) Nuclear Ab [Titer] in Serum

2394

9390

3.00

307.65

1.7

1.3

titre

557.7

508.5

0.59

654

1576

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

7273

30676

5.30

307.65

3.8

2.1

nmol/l

75.3

75.0

0.45

7015

27884

(3024980) IgG subclass 4 [Mass/volume] in Serum

565

920

6.43

307.65

2.3

1.3

g/l

0.8

0.7

0.66

462

681

(3013115) Eosinophils [#/volume] in Blood

8279

38833

6.05

307.65

13.6

4.6

e9/l

0.2

2.84

7736

33751

(3025159) Blasts/100 leukocytes in Blood

2012

4528

5.24

307.65

6.2

3.5

0.0

0.3

1.40

453

986

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

415

487

8.83

307.65

1.5

1.1

titre

264.8

141.8

1.69

163

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

526

595

9.25

307.65

2.0

1.1

titre

—

(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma

383

792.92

307.65

3.2

2.2

—

(3002030) Lymphocytes/100 leukocytes in Blood

7675

36778

4.87

307.65

13.6

4.4

28.4

29.2

9.32

7415

34139

(3022096) Basophils/100 leukocytes in Blood

7494

33803

5.09

307.65

13.6

4.4

0.7

29.78

7237

31330

(3034770) Mitochondria Ab [Titer] in Serum

1046

1983

5.74

307.65

1.7

1.2

titre

840.0

902.4

0.08

(3025941) Bacteria identified in Stool by Culture

1689

4543

4.23

307.65

1.5

1.2

—

(3021589) Normoblasts [#/volume] in Blood

6303

34867

2.97

307.65

16.2

7.4

e9/l

0.0

1.09

5603

28080

(44786774) Adalimumab [Mass/volume] in Serum or Plasma

519

118.54

307.65

2.6

1.7

mg/l

9.2

11.7

2.31

454

(3028026) IgM [Mass/volume] in Serum or Plasma

1416

3729

4.23

307.65

2.0

1.8

g/l

1.2

1.3

0.98

1332

3396

(3022948) Iron [Moles/volume] in Serum or Plasma

2551

10711

2.82

307.65

2.6

2.4

umol/l

13.3

14.0

4.87

2436

9937

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

709

1412

5.31

307.65

1.6

1.3

—

(3001122) Ferritin [Mass/volume] in Serum or Plasma

6034

36399

2.51

307.65

3.8

2.7

ug/l

102.0

112.0

1.75

5755

34093

(42870588) Differential panel, method unspecified - Blood

6361

23732

5.16

307.65

11.9

4.4

—

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

2347

8992

3.06

307.65

2.6

2.5

22.2

24.1

8.20

2045

7683

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

980

1199

8.90

307.65

3.4

5.1

iu/ml

777.3

2168.3

0.43

109

144

(3048689) Calprotectin [Mass/mass] in Stool

8125

9036

34.47

307.65

7.3

1.3

ug/g

221.5

93.7

106.84

7732

6811

(3005719) IgG [Mass/volume] in Serum or Plasma

1629

4836

3.79

307.65

2.7

2.1

g/l

11.5

10.6

13.62

1516

4384

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

182

115.70

307.65

1.0

1.2

—

(40758558) Short blood count panel - Blood

3591

18984

2.34

307.65

10.4

6.1

—

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

4754

17139

4.20

307.65

3.9

2.0

mg/l

2.8

0.16

4341

14542

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

2026

1285

19.23

307.65

1.7

1.5

iu/ml

3.0

1.6

0.23

450

259

(40760892) CBC W Ordered Manual Differential panel - Blood

4059

17229

3.19

307.65

9.7

3.2

—

(3022145) Colonoscopy Study observation

6419

7380

20.31

307.65

2.1

1.2

—

(3013707) Erythrocyte sedimentation rate by Westergren method

9030

58405

4.55

307.65

7.2

2.8

mm/h

11.5

10.1

19.08

8615

54102

(3046294) Neutrophil cytoplasmic Ab.classic [Titer] in Serum

414

487

8.80

307.65

1.5

1.1

titre

312.9

56.0

—

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

4944

27323

2.51

307.65

4.8

3.0

u/l

30.5

34.2

3.97

4551

25954

(3019069) Monocytes/100 leukocytes in Blood

7620

35303

5.05

307.65

13.8

4.6

8.7

8.4

15.64

7371

32931

(3013650) Neutrophils [#/volume] in Blood by Automated count

8497

43970

5.57

307.65

15.2

7.7

e9/l

3.9

4.0

3.05

7936

37818

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

3211

15171

2.60

307.65

1.6

1.7

—

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

9787

59793

8.67

307.65

16.9

6.0

u/l

74.2

76.6

8.91

9603

56123

(3006504) Eosinophils/100 leukocytes in Blood

7591

35078

5.03

307.65

13.5

4.4

2.8

2.9

2.52

7336

32513

(3018010) Neutrophils/100 leukocytes in Blood

7637

36205

4.90

307.65

12.9

4.3

57.3

56.3

14.62

7386

33754

(3004789) Transferrin [Mass/volume] in Serum or Plasma

2411

9837

2.87

307.65

2.6

2.4

g/l

2.4

4.39

2284

9102

(3019198) Lymphocytes [#/volume] in Blood

8216

38732

5.87

307.65

13.5

4.3

e9/l

1.9

2.0

13.91

7710

33788

(3021440) Promyelocytes/100 leukocytes in Blood

2081

4768

5.18

307.65

6.2

3.5

0.1

0.2

1.92

513

1168

(3042299) inFLIXimab [Mass/volume] in Serum or Plasma

1005

299.74

307.65

3.5

4.1

mg/l

8.5

7.0

1.05

852

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

1756

6468

3.05

307.65

3.6

2.2

g/l

0.2

11.43

1665

6009

(3006315) Basophils [#/volume] in Blood

8180

37341

6.10

307.65

13.5

4.3

e9/l

0.0

5.32

7622

31824

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

10226

86101

5.48

307.65

24.7

10.2

mg/l

15.9

23.4

155.81

9036

64978

(3002179) Metamyelocytes/100 leukocytes in Blood

2070

4533

5.42

307.65

5.6

3.3

0.4

0.7

6.00

432

912

(3001604) Monocytes [#/volume] in Blood

8159

37192

6.07

307.65

13.4

4.3

e9/l

0.6

0.76

7589

31718

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

3157

4068

10.60

307.65

2.2

1.5

—

(1175556) inFLIXimab Ab [Units/volume] in Serum by Immunoassay

882

266.97

307.65

2.8

3.5

au/ml

127.8

146.5

—

123

(3017143) Hepatitis C virus Ab [Presence] in Serum

2764

10649

3.15

307.65

1.5

1.7

—

(3024561) Albumin [Mass/volume] in Serum or Plasma

8045

30533

7.64

307.65

9.2

4.3

g/l

36.9

36.2

25.88

7778

28344

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

6166

39170

2.36

307.65

7.6

5.7

umol/l

10.7

11.4

6.42

5929

37016

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

776

1842

4.46

298.22

2.0

1.4

titre

483.2

153.0

2.58

(3009445) Proteinase 3 Ab [Units/volume] in Serum

884

2322

4.06

296.98

1.8

1.2

u/ml

5.6

5.0

0.12

103

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

703

1556

4.77

294.75

1.3

u/ml

278.6

244.2

1.99

414

999

(40768804) Tissue Pathology biopsy report

5105

32618

2.08

289.61

2.4

2.0

—

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

680

1501

4.77

285.91

1.9

1.2

iu/ml

7.2

10.3

0.34

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

720

1668

4.56

285.14

1.2

1.3

—

(3007164) IgA [Mass/volume] in Serum or Plasma

3001

16113

2.20

263.48

1.7

1.4

g/l

2.4

2.3

2.48

2133

9890

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

675

1615

4.39

256.08

1.4

1.3

—

(3003327) Ova and parasites identified in Stool by Light microscopy

926

2811

3.51

250.80

1.8

1.7

—

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

5253

35189

1.97

247.75

7.1

6.1

mmol/l

1.2

1.18

4400

29721

(36305790) Ustekinumab [Mass/volume] in Serum or Plasma by Immunoassay

238

403.10

237.70

2.2

mg/l

3.4

3.0

—

229

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

4821

31729

1.95

235.75

6.3

5.5

mmol/l

1.2

3.86

4423

28720

(46235355) HIV 1 and 2 tests - Meaningful Use set

3267

19300

2.00

214.33

1.8

2.0

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

428

816

5.42

212.61

1.7

1.4

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

421

794

5.48

211.64

1.6

1.4

—

(3032080) INR in Blood by Coagulation assay

4349

28395

1.90

210.97

8.5

7.4

inr

1.1

1.2

6.76

1497

8302

(3024522) Salmonella sp identified in Specimen by Organism specific culture

421

799

5.44

210.17

1.7

1.4

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

730

2136

3.59

208.24

1.4

1.1

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

733

2154

3.58

207.73

1.3

1.1

—

(3019309) Folate [Moles/volume] in Red Blood Cells

2265

11806

2.17

207.54

2.1

1.7

nmol/l

1158.9

1156.2

0.04

1572

9049

(42529406) Shigella sp [Presence] in Stool by Culture

735

2165

3.57

207.54

1.4

1.1

—

(3048929) Epstein Barr virus Ab [Presence] in Serum

870

2890

3.19

202.59

1.3

—

(3018418) pH of Serum or Plasma

3363

20387

1.95

202.40

4.1

3.8

7.4

0.42

643

3821

(3025468) Yersinia sp identified in Specimen by Organism specific culture

411

791

5.36

201.97

1.7

1.4

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

411

792

5.36

201.68

1.7

1.4

—

(3037467) Urinalysis macro (dipstick) panel - Urine

7125

54847

1.90

201.09

4.7

3.5

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

410

793

5.34

200.36

1.7

1.4

—

(3023368) Bacteria identified in Blood by Culture

3044

17957

1.97

197.60

4.8

3.9

—

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

442

929

4.92

196.26

1.4

1.2

—

(3014148) Varicella zoster virus Ab [Titer] in Serum

497

1153

4.47

195.48

1.1

1.2

—

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

9381

80024

2.42

194.93

19.2

9.9

ml/min/173m2

89.1

86.8

21.73

8213

64903

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

4379

29264

1.84

192.30

2.1

1.8

pmol/l

95.4

97.1

1.58

2640

15356

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

505

1212

4.32

190.07

1.1

—

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

853

2925

3.08

187.76

1.2

1.4

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

330

592

5.72

174.91

2.4

1.3

—

(3008092) Baker's yeast IgG Ab [Units/volume] in Serum

108

36.36

173.41

1.1

u/ml

26.7

17.3

—

(3004593) Baker's yeast IgA Ab [Units/volume] in Serum

108

36.36

173.41

1.1

u/ml

38.6

25.3

—

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

10267

92772

3.80

170.05

21.3

7.9

u/l

27.1

27.6

2.14

10149

89691

(40768797) Stomach Pathology biopsy report

1915

10071

2.10

167.64

1.3

1.2

—

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

1721

8746

2.15

164.48

4.1

2.6

umol/l

6.5

8.2

4.81

1524

7562

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

333

639

5.35

163.99

1.3

1.2

u/l

56.6

63.7

1.05

230

419

(3002385) Erythrocyte distribution width [Ratio]

8675

73274

1.98

160.71

26.3

13.1

13.7

13.5

22.38

8612

71682

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

2566

15154

1.91

160.65

2.4

1.6

pmol/l

33405978.6

33466438.1

0.00

2308

12813

(40768441) Liver Pathology biopsy report

270

439

6.28

158.28

1.8

1.4

—

(40761536) Microorganisms panel - Urine sediment

1367

6492

2.27

153.85

4.2

3.3

—

(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma

419

1028

4.20

152.90

4.1

2.9

u/ml

11.8

1578.5

0.95

410

955

(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection

170

171

10.09

149.74

1.7

1.6

u/ml

4055.8

24980.6

0.45

(3021879) Hepatitis B virus core Ab [Presence] in Serum

1409

6856

2.22

149.18

1.3

1.5

—

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

1467

7269

2.18

148.38

3.2

2.5

u/l

38.4

48.0

0.72

1306

6238

(3033658) Prothrombin time (PT) actual/Normal

3103

20006

1.78

143.53

5.7

3.6

94.2

91.8

7.22

3030

19506

(3010375) cycloSPORINE [Mass/volume] in Blood

176

207

8.63

137.71

19.2

27.3

ug/l

127.4

118.2

0.81

160

163

(3035350) Ketones [Presence] in Urine by Test strip

5187

38736

1.66

137.62

3.8

3.0

estimate

0.0

1.28

1445

6678

(3009261) Glucose [Presence] in Urine by Test strip

5239

39265

1.66

136.72

3.9

3.0

estimate

0.0

0.46

1456

6663

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

662

2349

2.94

136.16

5.2

3.6

u/ml

48.4

1740.4

0.91

587

2029

(3021601) Nitrite [Presence] in Urine by Test strip

5189

38894

1.65

134.57

5.0

4.1

estimate

0.0

1.34

1482

6892

(3036481) Cortisol [Moles/volume] in Serum or Plasma

1329

6588

2.16

133.37

2.2

nmol/l

331.6

387.3

22.44

1231

6045

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

385

987

4.01

132.24

1.1

g/l

1.5

0.04

358

885

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

2962

19249

1.75

131.02

1.3

u/ml

1.3

1.9

1.70

730

5467

(3004809) Band form neutrophils/100 leukocytes in Blood

350

842

4.26

130.97

3.0

3.2

1.0

1.7

3.11

266

641

(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma

214

362

6.01

120.49

1.4

1.2

u/l

81.4

81.8

0.02

178

314

(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma

210

350

6.10

120.04

1.4

1.2

u/l

22.7

17.4

0.55

176

297

(3017732) Neutrophils [#/volume] in Blood

1087

5208

2.21

118.08

2.9

2.5

e9/l

4.2

4.0

0.79

791

4217

(3029937) Albumin [Presence] in Urine by Test strip

3024

20270

1.69

116.92

4.3

3.3

estimate

0.0

0.23

1456

6607

(3013826) Glucose [Moles/volume] in Serum or Plasma

5766

45407

1.59

114.26

5.4

4.3

mmol/l

6.5

6.6

4.45

5419

41864

(3023103) Potassium [Moles/volume] in Serum or Plasma

9615

86767

2.09

112.06

18.9

12.4

mmol/l

3.9

4.0

52.50

9387

84282

(3019550) Sodium [Moles/volume] in Serum or Plasma

9588

86442

2.07

111.92

18.7

12.3

mmol/l

139.5

139.7

18.01

9376

84157

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

209

381

5.57

108.78

1.8

1.5

u/l

6.3

5.4

0.27

124

156

(3041672) Baker's yeast Ab [Presence] in Serum

27.09

102.60

1.1

1.0

—

(36304617) Golimumab [Mass/volume] in Serum or Plasma by Immunoassay

110

123.50

102.15

2.4

1.8

mg/l

2.1

1.8

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

944

4527

2.19

101.68

1.5

1.4

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

235

512

4.67

99.66

1.3

1.2

—

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

234

516

4.61

97.78

1.3

1.2

—

(3027945) Reticulocytes/100 erythrocytes in Blood

1266

6861

1.96

97.77

3.6

2.4

1.8

1.7

1.77

1139

6068

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

4103

30690

1.55

96.13

4.0

3.1

—

(3042936) Bacteria identified in Isolate by Culture

1666

9916

1.81

95.86

2.2

1.9

—

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

528

2013

2.71

94.32

1.2

1.3

—

(3008898) HLA-B27 [Presence]

663

2835

2.43

93.29

1.1

—

(3041096) Erythrocytes [Presence] in Urine by Automated

3121

22102

1.58

92.24

3.5

2.7

—

(3052851) Hemolysis interference index of Serum or Plasma

527

2038

2.67

91.50

3.2

2.9

—

(3021960) Folate [Moles/volume] in Serum or Plasma

2372

15754

1.65

91.17

1.6

1.5

nmol/l

20.6

20.3

0.43

2122

13640

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

143

218

6.63

89.23

1.2

—

(40761511) CBC panel - Blood by Automated count

9900

91531

2.13

89.01

18.7

10.1

—

(3017354) Segmented neutrophils/100 leukocytes in Blood

223

532

4.26

84.31

3.0

3.4

56.9

56.1

0.19

142

342

(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence

325

1008

3.29

83.80

1.3

1.1

titre

136.0

194.0

—

(3031040) Bacteria [#/volume] in Urine by Automated count

6261

52057

1.49

83.68

4.6

3.7

e6/l

1064.1

1658.6

0.29

688

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

325

1011

3.28

83.40

2.5

2.6

u/ml

967.9

763.4

0.18

(3008757) Leukocyte morphology finding [Identifier] in Blood

225

557

4.10

80.98

3.3

3.9

—

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

443

1671

2.72

80.68

1.3

1.4

—

(3006922) Hepatitis E virus Ab [Presence] in Serum

230

581

4.02

80.54

1.1

—

(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma

442

1668

2.72

80.43

1.3

1.4

u/ml

28.8

15.7

—

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

217

528

4.17

79.93

1.1

—

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

217

533

4.13

78.93

1.1

—

(3023520) Reticulocytes [#/volume] in Blood

926

4916

1.97

74.99

2.7

2.4

e9/l

73.8

69.6

1.98

710

3623

(3002582) Erythrocytes [#/volume] in Urine

3070

22489

1.51

74.47

3.4

2.8

e6/l

61.2

84.0

0.61

2461

16794

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

1810

11745

1.65

74.37

1.3

1.2

u/ml

7.6

4.8

1.39

675

4813

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

1175

6764

1.83

74.12

4.7

4.3

ug/l

15.0

26.9

0.61

913

5345

(3000850) Epithelial cells [#/volume] in Urine

2216

15121

1.59

74.05

2.7

2.3

e6/l

5.6

5.9

0.48

1978

13101

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

1624

10269

1.69

73.65

2.0

1.7

—

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

119

8.22

73.36

1.5

1.1

—

(3030467) Casts [#/volume] in Urine by Automated count

2828

20416

1.52

73.28

3.3

2.8

e6/l

0.4

0.37

2224

14923

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

457

1841

2.55

72.84

1.6

1.4

g/l

1.2

0.53

430

1759

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

406

1545

2.69

72.63

1.4

1.5

u/ml

112.8

113.7

0.04

335

(3018095) Leukocytes [#/volume] in Urine

3515

26602

1.48

72.11

3.8

3.2

e6/l

77.8

83.4

0.12

2626

18303

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

441

1755

2.58

72.09

1.6

1.4

g/l

0.2

2.97

413

1673

(3014576) Chloride [Moles/volume] in Serum or Plasma

1405

8627

1.72

70.81

8.8

7.0

mmol/l

104.8

104.6

0.59

1384

8448

(36304419) Bacteria [Presence] in Urine

2780

20140

1.51

70.31

3.2

2.7

—

(3012095) Magnesium [Moles/volume] in Serum or Plasma

1752

11426

1.64

70.15

4.0

3.2

mmol/l

0.8

8.53

1616

10699

(3015171) Extractable nuclear Ab [Units/volume] in Serum

560

2516

2.29

70.05

1.3

1.2

u/ml

1.0

0.8

0.11

219

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

1888

12633

1.60

67.81

1.3

1.2

iu/ml

22.1

19.9

0.35

583

3676

(3003458) Phosphate [Moles/volume] in Serum or Plasma

1435

8967

1.69

67.57

6.0

5.7

mmol/l

1.0

1.47

1345

8410

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

450

1880

2.45

66.33

1.9

1.5

—

(3026782) Osmolality of Urine

2060

14200

1.56

64.71

2.8

2.4

mosm/kgh2o

546.8

556.8

1.14

1798

11998

(3024139) IgG subclass 3 [Mass/volume] in Serum

204

559

3.70

63.69

1.4

1.2

g/l

0.4

0.11

125

368

(3028192) IgG subclass 2 [Mass/volume] in Serum

204

559

3.70

63.69

1.4

1.2

g/l

3.1

0.08

125

374

(3027135) IgG subclass 1 [Mass/volume] in Serum

204

559

3.70

63.69

1.4

1.2

g/l

8.0

6.6

3.58

126

369

(4062490)

203

555

3.71

63.59

1.4

1.2

—

(3007461) Platelets [#/volume] in Blood

10348

98901

2.52

61.13

33.5

15.6

e9/l

268.9

252.0

114.00

10265

96400

(3023420) DNA double strand Ab [Units/volume] in Serum

188

502

3.79

60.95

1.4

1.3

iu/ml

19.4

23.2

—

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

167

414

4.08

60.05

1.1

miu/ml

1654.9

1520.9

0.71

167

414

(3024731) MCV [Entitic volume]

10349

99011

2.49

59.26

33.3

15.6

91.3

90.3

95.08

10302

97746

(3035941) MCH [Entitic mass]

10348

98998

2.49

59.25

33.3

15.6

30.4

30.2

22.28

10301

97735

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

155

367

4.27

59.25

1.5

1.4

—

(3000570) Elastase.pancreatic [Mass/mass] in Stool

461

2047

2.31

59.18

1.5

1.4

ug/g

282.0

274.5

0.31

272

1167

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

157

376

4.22

59.12

1.5

1.4

—

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

339

1307

2.65

59.06

5.1

3.6

u/ml

115.6

693.3

1.89

306

1202

(3026361) Erythrocytes [#/volume] in Blood

10349

99024

2.48

59.01

33.5

15.6

e12/l

4.5

4.6

46.75

10247

96289

(3015377) Calcium [Moles/volume] in Serum or Plasma

3180

24320

1.44

58.91

3.3

mmol/l

2.3

2.4

3.64

2811

21486

(3000963) Hemoglobin [Mass/volume] in Blood

10349

99066

2.47

58.20

33.6

15.7

g/l

136.1

137.8

27.46

10300

97795

(3010813) Leukocytes [#/volume] in Blood

10348

99053

2.47

58.19

33.5

15.7

e9/l

6.8

6.6

15.18

10249

96278

(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma

211

633

3.38

57.42

1.1

mg/l

286.6

284.1

0.18

189

570

(3032057) Clostridioides difficile [Presence] in Stool

112

7.37

56.63

2.1

1.9

—

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

2336

16971

1.48

56.14

1.9

1.7

mg/l

1.1

0.38

1793

12592

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

129

276

4.72

56.02

1.5

1.4

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

129

276

4.72

56.02

1.5

1.4

—

(3020779) Urea [Moles/volume] in Serum or Plasma

1002

5977

1.75

55.22

8.5

7.0

mmol/l

8.3

8.8

1.42

945

5721

(3007853) Bacteria identified in Skin by Aerobe culture

1337

8610

1.63

55.21

1.8

1.6

—

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

3434

26946

1.40

53.92

3.4

2.9

ng/l

39.0

51.7

0.75

2087

16074

(3044640) Blood type and Crossmatch panel - Blood

3186

24855

1.40

51.11

2.9

2.2

—

(4035726)

1027

6308

1.69

50.70

1.4

1.3

—

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

442

2057

2.20

50.62

4.0

3.4

mg/l

1.4

0.29

404

1905

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

1112

7004

1.66

49.83

1.9

1.6

—

(3016650) Hepatitis A virus Ab [Presence] in Serum

334

1400

2.43

48.83

1.1

—

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

1100

6947

1.65

48.72

1.8

1.6

—

(3013005) Retinol [Moles/volume] in Serum or Plasma

127

303

4.23

48.12

2.5

1.7

umol/l

2.0

1.9

0.38

119

280

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

1136

7268

1.63

47.74

3.6

4.3

u/l

226.0

235.3

2.21

1076

6879

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

4577

38183

1.35

47.16

4.7

3.8

—

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

6907

61304

1.36

47.00

4.5

2.9

u/l

51.6

43.8

7.96

6560

57975

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

313

1300

2.45

46.69

1.7

1.5

—

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

1112

7116

1.63

46.63

3.4

3.0

—

(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma

128

317

4.07

46.16

1.1

u/l

24.4

21.8

0.09

105

231

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

521

2683

1.99

45.55

1.8

1.6

g/l

1.4

1.5

0.61

450

2297

(3020961) Endomysium IgA Ab [Titer] in Serum

724

4152

1.80

45.40

1.1

titre

41.0

211.7

—

139

(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma

127

319

4.02

44.94

1.1

u/l

78.7

85.7

0.25

111

243

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

118

286

4.16

43.82

1.3

1.2

—

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

321

1413

2.31

42.03

1.1

—

(3000494) Fungus identified in Specimen by Culture

1300

8833

1.54

41.85

1.6

1.4

—

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

360

1673

2.19

41.36

2.6

2.4

—

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

100

223

4.52

41.36

1.2

—

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

517

2753

1.92

40.95

1.8

1.5

u/l

38.6

39.6

0.58

447

2450

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

2443

18800

1.39

40.70

2.8

2.1

—

(3009542) Hematocrit [Volume Fraction] of Blood

8919

83203

1.44

40.37

22.4

11.6

40.3

40.5

2.59

6714

65089

(3019225) pH of Specimen

1015

6570

1.60

40.33

3.9

3.7

—

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

295

1280

2.34

39.94

1.7

1.6

—

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

433

2192

2.02

39.70

2.0

1.9

ug/l

5.4

2.4

0.43

391

1934

(3002032) Base excess in Venous blood by calculation

960

6177

1.61

39.05

4.9

3.8

mmol/l

1.6

1.8

0.53

777

5022

(3005322) IgE [Units/volume] in Serum or Plasma

756

4577

1.70

39.03

1.3

1.2

u/ml

245.9

179.9

0.69

702

4198

(3004588) Protein electrophoresis panel - Serum or Plasma

634

3675

1.77

38.21

2.0

2.4

—

(3026008) Bacteria identified in Urine by Culture

2619

20597

1.36

37.60

3.1

2.7

—

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

105

263

4.02

37.36

3.7

2.6

—

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

220

863

2.58

37.09

1.8

1.6

—

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

215

834

2.61

37.08

1.5

1.1

—

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

290

1300

2.27

36.40

1.2

u/ml

3.7

1.7

0.71

(3021447) Carbon dioxide [Partial pressure] in Venous blood

952

6217

1.58

36.28

5.0

3.8

kpa

5.8

0.19

919

6029

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

864

5551

1.61

35.24

4.1

3.5

mmol/l

1.2

0.36

756

4830

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

106

279

3.83

35.23

1.5

1.3

—

(3000991) Gas panel - Venous blood

896

5816

1.59

34.99

9.9

8.5

—

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

1684

12438

1.42

34.98

2.9

2.5

e6/l

0.9

1.1

0.75

983

6721

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

127

5.38

34.63

1.2

1.1

—

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

574

3354

1.75

33.60

5.3

4.2

mmol/l

24.0

24.1

0.09

534

3026

(3011397) Hemoglobin [Presence] in Urine by Test strip

2240

17453

1.36

33.53

3.7

3.0

—

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

362

1829

2.01

33.38

1.3

1.2

u/ml

26.3

33.8

0.24

104

(36660697) Celiac disease serology panel - Serum

1018

6877

1.53

33.24

1.2

—

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

331

1624

2.07

33.08

1.3

1.2

u/ml

6.2

2.6

0.94

125

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

330

1620

2.07

32.93

1.9

1.5

mg/l

11.4

10.7

0.69

300

1508

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

334

1648

2.06

32.88

1.3

1.2

u/ml

12.4

6.5

1.06

225

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

754

4765

1.63

32.85

3.9

ng/l

86.2

87.9

0.17

669

4163

(3022217) INR in Platelet poor plasma by Coagulation assay

1197

8401

1.48

32.46

21.1

20.2

inr

1.3

0.24

201

1248

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

151

524

2.91

32.28

1.2

—

(3020630) Protein [Mass/volume] in Serum or Plasma

746

4722

1.62

32.28

2.1

2.7

g/l

67.0

66.9

0.05

696

4332

(3026493) Urate [Moles/volume] in Serum or Plasma

2429

19257

1.34

32.21

2.6

2.2

umol/l

4064.3

4102.7

0.02

2157

16907

(3011412) CD3 cells [#/volume] in Blood

162

592

2.76

31.48

1.9

2.9

e9/l

1.1

1.2

0.29

344

(3020393) Adenovirus Ag [Presence] in Stool

6.52

31.00

1.7

1.1

—

(40768443) Skin Pathology biopsy report

520

3031

1.75

30.68

1.2

—

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

1584

11822

1.40

30.60

3.1

2.6

e6/l

2.8

2.6

0.26

888

6142

(3010503) CD19 cells [#/volume] in Blood

113

345

3.30

30.08

1.9

3.3

e9/l

0.3

0.4

0.09

108

338

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

176

688

2.58

29.96

1.7

1.3

—

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

651

4086

1.63

29.09

4.5

3.1

kpa

5.1

1.60

603

3781

(3009871) Measles virus Ab [Titer] in Serum

248

3.69

28.84

1.6

1.7

—

(3009343) pH of Capillary blood

643

4036

1.63

28.72

4.6

3.0

7.4

1.00

504

(3003396) Base excess in Arterial blood by calculation

1071

7559

1.46

28.01

8.5

7.5

mmol/l

0.8

0.14

830

5855

(3016502) Oxygen saturation in Arterial blood

967

6699

1.49

27.79

9.0

8.0

96.3

96.1

0.57

931

6440

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

2637

21532

1.30

27.56

2.2

2.0

u/l

207.1

227.5

0.28

2513

20272

(3020717) Zinc [Moles/volume] in Serum or Plasma

119

396

3.03

27.47

1.9

1.5

umol/l

23.0

25.1

0.30

112

382

(3027801) Oxygen [Partial pressure] in Arterial blood

1066

7544

1.46

27.47

8.5

7.5

kpa

12.7

13.1

1.87

1017

7211

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

1066

7545

1.46

27.45

8.6

7.5

kpa

5.0

5.1

1.60

1014

7217

(3004616) Nuclear Ab [Presence] in Serum

174

706

2.49

27.44

1.3

—

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

215

967

2.25

26.87

1.5

1.3

—

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

196

848

2.34

26.83

1.5

1.3

—

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

616

3902

1.61

26.49

4.6

3.0

mmol/l

1.4

1.6

0.38

456

2818

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

2137

17055

1.32

26.25

3.0

2.7

ng/l

1389.2

1182.5

1.12

1790

14213

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

169

693

2.46

26.08

1.5

1.2

—

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

6938

63718

1.25

25.81

3.3

3.2

—

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

670

4360

1.57

25.71

8.5

7.1

mmol/l

24.5

24.7

0.38

661

4331

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

1610

12383

1.35

25.39

3.1

3.0

mmol/l

2.4

0.87

1397

10797

(3014111) Lactate [Moles/volume] in Serum or Plasma

875

6048

1.49

25.36

8.2

7.2

mmol/l

1.3

0.17

839

5823

(3019060) Gas panel - Arterial blood

620

4012

1.58

24.36

5.4

5.0

—

(3052592) Norovirus Ag [Presence] in Stool

113

4.80

24.25

2.0

1.3

—

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

244

1203

2.05

24.16

1.5

1.2

—

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

429

2535

1.72

24.12

1.1

u/ml

3.0

5.9

1.26

414

(3002173) Hemoglobin [Mass/volume] in Arterial blood

900

6319

1.46

24.05

9.4

8.3

g/l

120.9

122.7

1.84

870

6076

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

164

696

2.38

23.51

1.0

1.1

—

(3018677) aPTT in Platelet poor plasma by Coagulation assay

1452

11126

1.35

23.30

2.4

2.0

30.0

29.7

1.00

1402

10803

(3037692) Legionella sp identified in Specimen by Organism specific culture

122

4.53

23.04

1.3

1.1

—

(3042733) HLA Ab [Presence] in Serum

231

3.44

22.62

3.1

5.4

—

(3028433) Virus identified in Specimen by Culture

198

3.65

22.60

1.1

1.2

—

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

140

563

2.51

22.58

1.8

1.3

—

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

122

460

2.67

22.44

1.9

3.0

e6/l

493.1

538.1

0.45

102

390

(3023419) Bacteria identified in Sputum by Culture

130

507

2.58

22.35

3.0

2.3

—

(40761535) Cells panel - Urine sediment

795

5527

1.47

22.31

3.5

2.9

—

(3021788) Differential panel - Synovial fluid

181

823

2.22

22.11

1.6

1.3

—

(3039162) Centromere protein B Ab [Units/volume] in Serum

178

804

2.23

22.10

1.2

u/ml

14.8

64.1

3.15

(3024354) Oxygen [Partial pressure] in Venous blood

745

5123

1.49

22.08

4.3

3.2

kpa

4.6

4.7

0.43

713

4953

(3026389) Candida sp identified in Specimen by Organism specific culture

222

1097

2.05

21.88

1.3

—

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

269

1423

1.91

21.81

1.3

1.2

u/ml

30.8

38.8

0.32

104

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

126

498

2.55

21.11

1.7

1.3

53.0

59.0

0.76

294

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

7037

65323

1.23

20.95

3.8

pmol/l

14.7

14.6

5.15

6459

60100

(3000475) Leukocytes [#/volume] in Synovial fluid

221

1109

2.01

20.90

1.7

1.4

e6/l

11050.1

15385.9

1.17

167

755

(1616796) Gas panel - Central venous blood

268

1442

1.88

20.65

3.2

3.1

—

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

162

728

2.24

20.40

1.6

1.2

—

(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay

119

469

2.55

20.07

3.1

2.1

90.8

95.8

0.88

113

434

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

851

6111

1.43

20.07

3.0

2.4

ml/min/173m2

70.7

72.4

0.55

346

2252

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

323

1861

1.76

19.91

1.7

—

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

115

448

2.58

19.87

1.9

3.0

e9/l

0.2

5.61

101

388

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

202

3.43

19.77

2.0

4.0

—

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

1726

13852

1.29

19.67

3.5

3.2

ng/l

432.5

556.6

0.42

1194

9855

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

358

2133

1.70

19.57

1.8

2.3

g/l

3.9

3.8

0.46

260

1518

(3012501) Base excess in Blood by calculation

272

1497

1.84

19.54

4.1

3.4

mmol/l

2.5

2.3

0.34

180

963

(3027315) Oxygen [Partial pressure] in Blood

273

1505

1.84

19.51

4.1

3.4

kpa

8.8

8.9

0.19

265

1473

(3013290) Carbon dioxide [Partial pressure] in Blood

272

1498

1.84

19.50

4.1

3.4

kpa

5.0

0.04

264

1467

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

358

2136

1.70

19.47

1.8

2.3

—

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

358

2138

1.70

19.41

1.8

2.3

g/l

7.2

0.17

268

1611

(3036071) Salmonella sp Ab [Titer] in Serum

191

3.47

19.26

1.1

—

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

139

601

2.33

19.19

1.5

1.7

—

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

339

2001

1.72

19.19

3.3

3.1

u/ml

0.3

0.11

176

1111

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

340

2012

1.71

19.07

1.9

2.4

g/l

3.1

3.0

1.69

266

1575

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

2264

18854

1.25

18.98

1.7

1.6

—

(3042631) Mycobacterium sp identified in Specimen

142

623

2.30

18.96

3.0

2.5

—

(3034860) Kappa light chains.free [Mass/volume] in Serum

292

1662

1.78

18.79

2.6

3.6

mg/l

42.7

54.0

1.44

237

1365

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

236

1259

1.89

18.71

1.6

1.5

—

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

285

1615

1.79

18.62

2.6

3.5

ratio

1.4

3.1

1.16

131

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

114

457

2.51

18.60

1.2

1.1

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

114

457

2.51

18.60

1.2

1.1

—

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

291

1660

1.77

18.58

2.6

3.6

mg/l

37.7

45.9

0.71

235

1362

(3019150) Specific gravity of Urine by Refractometry

2072

17117

1.26

18.56

4.1

3.2

kg/l

1.0

0.36

296

2536

(44806118)

144

644

2.25

18.39

1.6

1.4

—

(44790047)

144

644

2.25

18.39

1.6

1.4

—

(44790048)

144

644

2.25

18.39

1.6

1.4

—

(44790049)

144

644

2.25

18.39

1.6

1.4

—

(3008152) Bicarbonate [Moles/volume] in Arterial blood

596

4065

1.49

18.37

7.5

7.0

mmol/l

24.1

24.4

0.83

560

3771

(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood

120

496

2.44

18.34

1.8

3.1

e6/l

706.7

727.9

0.12

191

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

114

461

2.49

18.27

1.2

1.1

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

114

461

2.49

18.27

1.2

1.1

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

114

462

2.48

18.18

1.2

1.1

—

(3026250) Tacrolimus [Mass/volume] in Blood

308

2.84

18.13

43.3

34.3

ug/l

7.1

7.6

1.71

285

(3022313) Gas panel - Capillary blood

453

2920

1.58

18.11

5.1

3.1

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

113

457

2.49

18.11

1.2

1.1

—

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

309

1810

1.73

18.00

1.9

2.3

g/l

0.8

0.07

268

1570

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

335

2008

1.69

17.94

1.9

2.3

g/l

10.5

10.2

0.50

280

1684

(3010421) pH of Blood

301

1753

1.74

17.90

4.0

3.5

7.4

0.41

264

1468

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

379

2347

1.64

17.90

2.8

2.6

g/l

3.5

3.6

0.33

358

2236

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

545

3671

1.51

17.85

1.7

1.6

—

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

582

3979

1.49

17.73

1.5

1.4

—

(3051651) Icteric interference index of Serum or Plasma

104

409

2.56

17.68

3.9

3.5

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

111

451

2.48

17.62

1.6

1.8

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

111

451

2.48

17.62

1.6

1.8

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

111

451

2.48

17.62

1.6

1.8

—

(40767503) Oxygen content in Capillary blood by calculation

248

1375

1.82

17.44

2.3

2.1

16.7

16.8

0.05

123

679

(40760888) Immunoglobulin light chains.free panel - Serum

227

1228

1.87

17.27

2.6

3.8

—

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

101

399

2.55

17.03

1.8

1.3

—

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

279

1617

1.74

16.90

1.8

2.2

g/l

0.0

0.31

258

1481

(3015235) Bicarbonate [Moles/volume] in Capillary blood

268

1541

1.76

16.70

4.0

2.7

mmol/l

24.3

24.5

0.36

233

1346

(3034274) Bile acid [Moles/volume] in Serum --fasting

234

1298

1.82

16.46

2.4

2.2

umol/l

13.2

6.4

2.56

179

959

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

8225

78227

1.22

16.39

4.5

4.4

mu/l

1.7

2.1

5.60

7666

72625

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

419

2718

1.56

16.32

2.2

1.9

—

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

104

427

2.45

16.19

1.7

2.3

—

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

121

532

2.29

16.15

1.6

1.8

—

(3031067) HIV 1 p24 Ag [Mass/volume] in Serum or Plasma by Immunoassay

7.87

16.14

1.0

—

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

260

1499

1.75

16.06

1.9

2.2

g/l

0.0

1.01

239

1370

(21494815) CD4 cells/100 lymphocytes in Specimen

129

585

2.22

15.99

1.8

2.6

52.5

39.6

1.95

(3003329) Lymphocytes/100 leukocytes in Synovial fluid

384

2.51

15.80

1.7

1.3

31.8

27.6

0.46

233

(3023183) Ammonium ion [Moles/volume] in Plasma

266

1553

1.73

15.73

3.9

2.8

umol/l

31.3

35.3

2.80

234

1336

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

281

1668

1.70

15.65

1.8

2.1

g/l

37.8

38.5

1.07

244

1441

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

256

1481

1.75

15.64

1.9

2.2

g/l

0.0

0.00

236

1369

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

372

2373

1.59

15.59

2.4

2.5

186.4

178.2

1.01

346

2254

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

398

2579

1.56

15.59

2.1

2.2

93.1

92.7

0.11

373

2402

(3024891) Influenza virus A+B Ag [Presence] in Specimen

349

2193

1.61

15.58

1.2

1.1

—

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

403

2630

1.55

15.30

5.1

3.2

mmol/l

24.7

0.20

378

2442

(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum

105

446

2.37

15.19

1.2

u/ml

12.1

40.3

—

(3036489) Thrombin time

450

3015

1.51

15.14

2.0

2.1

21.5

21.2

0.57

388

2595

(1175426) CD3 cells/100 lymphocytes in Blood

111

487

2.29

14.92

1.7

2.3

73.4

72.3

0.35

105

474

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

543

3791

1.46

14.89

12.3

9.8

—

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

168

3.29

14.84

1.4

1.5

ug/l

10.3

9.3

0.58

168

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

384

2504

1.55

14.65

2.0

1.7

—

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

203

1119

1.83

14.62

1.5

1.4

—

(3044889) 12 lead EKG panel

6083

56555

1.18

14.54

3.5

3.2

—

(3028271) Lactate [Moles/volume] in Capillary blood

189

1027

1.86

14.26

1.9

1.6

mmol/l

1.8

0.06

184

999

(3051611) Lipemic interference index of Serum or Plasma

138

674

2.06

14.21

3.9

3.2

—

(3013512) EKG study

2390

20544

1.21

14.20

3.5

3.4

—

(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood

108

481

2.26

14.05

1.7

2.3

11.3

15.2

1.86

246

(3047181) Lactate [Moles/volume] in Blood

343

2204

1.57

13.97

7.3

5.8

mmol/l

1.3

0.54

306

1934

(3028626) Oxygen [Partial pressure] in Capillary blood

252

1502

1.69

13.87

6.1

2.9

kpa

8.7

8.6

0.05

231

1395

(3034891) Synovial lining cells/100 cells in Synovial fluid

182

3.09

13.67

1.6

1.3

4.6

3.4

0.23

(3003181) Sodium [Moles/volume] in Urine

186

1021

1.84

13.61

2.1

1.4

mmol/l

63.1

65.1

0.24

126

824

(3035947) Staphylolysin Ab [Units/volume] in Serum

277

2.65

13.45

1.1

iu/ml

2.0

3.8

—

(3014007) Fractional oxyhemoglobin in Arterial blood

591

4275

1.40

13.34

10.5

9.5

94.6

94.2

1.40

584

4264

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

273

2.65

13.29

1.7

2.2

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

273

2.65

13.29

1.7

2.2

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

273

2.65

13.29

1.7

2.2

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

273

2.65

13.29

1.7

2.2

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

1357

11059

1.26

13.26

1.4

—

(44816559) Phosphatidylethanol [Mass/volume] in Blood

300

1892

1.60

13.25

1.3

1.4

—

(3011325) HIV 1+2 Ab [Presence] in Serum

5.91

13.04

1.0

1.1

—

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

101

452

2.25

13.02

1.1

—

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

160

850

1.90

13.00

6.5

6.3

mg/l

11.9

11.0

1.45

150

788

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

248

2.71

12.97

3.0

—

(3002256) Pathology report gross observation

1276

10350

1.26

12.96

1.3

1.2

—

(44817194) Complement alternate pathway AH50 actual/normal in Serum by Immunoassay

130

3.39

12.56

1.0

1.1

99.6

92.3

0.74

130

(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma

130

3.39

12.56

1.0

1.1

—

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

356

2.37

12.31

1.2

u/ml

0.2

0.8

0.74

104

(3013293) Extractable nuclear Ab [Presence] in Serum

4.36

12.12

1.5

—

(3006217) Methemoglobin/Hemoglobin.total in Arterial blood

578

4246

1.38

11.92

10.6

9.5

0.7

1.09

572

4220

(3004119) Hemoglobin [Mass/volume] in Venous blood

558

4089

1.38

11.69

4.2

3.3

g/l

130.2

131.9

0.91

537

4002

(3045414) Leukocytes [Presence] in Urine

465

3303

1.43

11.67

1.8

—

(3024471) HLA-A [Type]

246

2.61

11.55

1.0

—

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

229

1401

1.65

11.49

1.1

u/ml

2.0

3.4

2.71

782

(3044941) Cell count panel - Synovial fluid

142

764

1.87

11.16

1.5

1.3

—

(3001186) Copper [Moles/volume] in Serum or Plasma

194

2.79

11.11

1.4

1.2

umol/l

16.7

0.01

168

(3037756) Immunofixation for Serum or Plasma

180

1042

1.74

11.11

1.8

—

(3003338) MCHC [Mass/volume]

8143

78151

1.18

11.11

27.3

13.5

g/l

332.4

333.6

30.90

8120

77566

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

215

1308

1.66

11.05

1.4

1.2

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

215

1308

1.66

11.05

1.4

1.2

—

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

159

2.96

10.79

1.7

2.3

—

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

488

3545

1.39

10.79

11.4

9.8

mmol/l

23.9

24.1

0.74

457

3336

(3044927) Protein electrophoresis panel - Urine

470

2.10

10.71

1.1

—

(3024932) HLA-DR beta [Type]

244

2.55

10.70

1.1

—

(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood

571

4262

1.36

10.68

10.6

9.4

1.3

1.4

2.18

564

4237

(3024889) Methemoglobin/Hemoglobin.total in Venous blood

430

3062

1.42

10.67

3.6

2.8

0.7

0.42

416

2934

(21494814) CD8 cells/100 lymphocytes in Specimen

233

2.58

10.64

1.6

2.4

—

(3052318) Alpha-1-Microglobulin [Mass/volume] in Urine

110

3.37

10.51

2.9

2.1

mg/l

37.2

50.3

—

(4010399)

635

4831

1.33

10.47

1.4

1.3

—

(3018461) Alpha 1 globulin [Mass/time] in 24 hour Urine by Electrophoresis

3.69

10.38

5.6

4.5

ug/min

37.3

39.4

0.08

(3010144) Erythrocytes [#/volume] in Synovial fluid

398

2.17

10.31

1.2

e6/l

166669.0

155002.4

0.04

275

(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma

127

3.16

10.24

1.9

1.6

ug/l

0.4

0.20

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

194

1174

1.66

10.21

1.5

1.6

—

(3039000) Anion gap in Blood

242

1550

1.57

10.12

8.5

6.9

mmol/l

11.6

11.2

1.20

223

1385

(3018572) Chloride [Moles/volume] in Blood

242

1551

1.57

10.09

8.5

6.9

mmol/l

104.8

105.3

0.95

223

1386

(3018405) Lactate [Moles/volume] in Arterial blood

327

2238

1.48

10.04

3.8

4.1

mmol/l

1.4

0.00

317

2204

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

665

5125

1.32

10.03

2.9

2.5

ng/l

185.1

164.9

0.54

589

4612

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

705

5478

1.31

10.01

2.4

2.1

ug/l

6.3

7.2

0.67

623

4824

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

386

2742

1.42

9.74

6.6

5.1

1.7

0.12

366

2558

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

238

2.49

9.71

1.1

—

(3007930) Methemoglobin/Hemoglobin.total in Blood

381

2702

1.43

9.70

6.7

5.1

0.9

0.92

360

2524

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

326

2250

1.46

9.60

2.3

ug/l

245.3

702.2

2.47

296

2109

(3006184) Hemoglobin [Mass/volume] in Capillary blood

227

1454

1.57

9.52

2.4

2.0

g/l

130.5

131.7

0.31

172

1078

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

629

4847

1.32

9.50

1.0

1.1

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

208

2.56

9.25

1.7

2.5

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

208

2.56

9.25

1.7

2.5

—

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

332

2317

1.45

9.24

1.3

—

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

289

2.29

9.09

1.1

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

210

2.53

9.08

1.7

2.5

—

(3021901) Oxygen saturation in Capillary blood

178

1088

1.65

9.07

3.9

2.4

—

(3027273) Bicarbonate [Moles/volume] in Venous blood

421

3076

1.38

9.05

4.2

3.2

mmol/l

24.9

25.2

0.95

406

2979

(3003740) Influenza virus B Ag [Presence] in Specimen

254

1690

1.52

8.99

1.1

—

(3002523) Influenza virus A Ag [Presence] in Specimen

254

1691

1.51

8.97

1.1

—

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

143

827

1.74

8.95

1.2

1.1

—

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

317

2.22

8.91

1.9

1.2

—

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

200

1265

1.59

8.88

1.3

1.2

u/ml

3.7

0.01

103

561

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

184

2.62

8.80

4.7

3.9

—

(3000492) Spirometry study

988

8151

1.23

8.53

1.5

1.3

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

272

2.29

8.53

2.0

1.3

—

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

332

2.15

8.38

1.8

1.3

u/ml

16.8

19.9

0.30

(4015189)

3.24

8.32

1.8

1.6

—

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

180

1129

1.60

8.31

1.1

—

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

469

1.95

8.26

3.6

3.7

—

(3018851) Theophylline [Moles/volume] in Serum or Plasma

14.46

8.19

2.4

umol/l

41.8

39.6

—

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

165

1018

1.63

8.15

2.6

2.5

—

(3020891) Body temperature

357

2586

1.39

8.12

5.2

4.7

—

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

156

950

1.65

8.11

1.3

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

183

1162

1.58

8.04

1.2

—

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

170

2.59

7.98

2.5

3.2

—

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

547

6988

0.77

7.91

1.3

1.4

—

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

355

2.06

7.82

1.4

1.2

u/l

5.5

5.9

0.28

307

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

270

2.23

7.81

2.0

1.3

—

(3045424) Erythrocytes [Presence] in Urine

183

1176

1.57

7.66

1.3

1.4

—

(3043409) Potassium [Moles/volume] in Arterial blood

275

1923

1.44

7.65

3.9

4.3

mmol/l

3.8

3.9

0.75

258

1806

(3004451) EKG impression Narrative

273

2.20

7.62

1.3

1.2

—

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

197

1289

1.54

7.61

3.5

3.0

—

(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum

449

3413

1.33

7.53

1.1

u/ml

55.4

1.6

—

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

199

1310

1.53

7.48

1.3

1.2

u/ml

4.9

3.3

0.67

406

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

299

2140

1.41

7.33

1.2

—

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

246

2.24

7.29

1.1

—

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

3.30

7.22

1.9

1.4

—

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

3.06

7.14

1.7

1.2

—

(42870325) Hepcidin 25 amino acid peptide [Moles/volume] in Serum or Plasma

3.18

7.09

1.3

1.7

nmol/l

7.5

532400.1

1.08

(3017704) Immunofixation for Urine

276

2.14

7.03

1.4

1.7

—

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

557

1.78

6.92

1.1

1.2

—

(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection

4.58

6.92

1.3

2.7

—

(3030981) Hyaline casts [#/volume] in Urine by Automated count

488

3803

1.30

6.86

2.8

2.4

e6/l

0.3

0.08

473

3687

(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma

342

1.99

6.70

1.1

iu/ml

179.4

180.0

0.01

342

(40761539) Cells [Type] in Urine sediment by Light microscopy

168

2.45

6.65

1.1

1.3

—

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

3.06

6.45

2.0

1.4

—

(3049717) Cytology report of Urine Cyto stain

319

2363

1.36

6.41

2.5

2.6

—

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

565

1.74

6.34

1.2

1.1

—

(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum

358

1.93

6.25

1.2

1.1

u/ml

9.0

18.5

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

1638

14513

1.15

6.21

1.6

1.5

—

(3016284) Epstein Barr virus nuclear Ab [Units/volume] in Serum

5.79

6.10

1.0

1.1

—

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

260

2.08

6.03

1.1

—

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

3.45

5.99

1.1

1.5

—

(3010015) Selenium [Moles/volume] in Serum or Plasma

3.19

5.85

2.8

1.8

umol/l

1.2

1.3

0.92

(3016038) Potassium [Moles/volume] in Urine

404

1.84

5.78

1.9

1.2

mmol/l

35.1

34.9

0.02

356

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

327

1.93

5.74

1.1

1.2

—

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

174

2.30

5.74

1.2

1.1

—

(3022621) pH of Urine by Test strip

607

4970

1.23

5.69

3.1

2.5

—

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

671

5554

1.22

5.67

2.3

au/ml

24.2

21.4

0.24

394

(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence

308

1.95

5.65

1.3

1.2

titre

60.0

58.5

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

879

10299

0.84

5.65

1.5

1.7

—

(3000060) B lymphocytes [#/volume] in Blood

188

2.24

5.64

1.7

2.4

e6/l

200.0

282.0

0.31

102

(3028679) Herpes simplex virus Ab [Presence] in Serum

482

1.75

5.58

1.2

—

(3033670) Parathyrin related protein [Moles/volume] in Serum or Plasma

104

2.70

5.57

1.2

1.1

pmol/l

5.1

5.6

—

(3009876) Amylase isoenzyme 3 panel - Serum or Plasma

3.47

5.44

1.3

1.2

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

135

880

1.54

5.44

1.1

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

501

1.72

5.43

1.5

1.2

—

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

341

1.88

5.42

1.1

1.2

—

(3029075) Extractable nuclear Ab panel - Serum

199

2.17

5.35

1.0

1.1

—

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

615

5078

1.22

5.34

1.3

au/ml

57.1

48.5

0.33

218

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

482

1.73

5.31

1.2

1.1

ratio

1.0

1.1

2.46

165

(3001964) Herpes simplex virus Ag [Presence] in Specimen

181

2.21

5.26

1.3

1.2

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

386

3027

1.29

5.26

1.5

1.4

—

(3037121) Protein [Mass/volume] in Urine

314

2397

1.32

5.23

3.0

3.2

g/l

0.3

0.12

153

1070

(3042111) Morphology [Interpretation] in Bone marrow Narrative

147

985

1.50

5.23

1.5

1.6

—

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

449

3597

1.26

5.15

2.4

2.3

—

(3019420) Tryptase [Mass/volume] in Serum or Plasma

377

1.81

5.10

1.2

1.6

ug/l

6.6

8.3

0.82

334

(40768446) Kidney Pathology biopsy report

279

1.94

5.03

1.7

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

121

785

1.55

5.01

1.1

—

(21494890) Protein electrophoresis panel - 24 hour Urine

574

1.64

5.01

1.7

2.2

—

(3017315) Amylase [Enzymatic activity/volume] in Urine

425

1.75

4.95

1.5

1.2

u/l

331.8

369.8

0.13

386

(4268621)

136

908

1.50

4.94

2.4

2.3

—

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

182

1286

1.42

4.94

1.1

125.4

116.3

3.44

165

1170

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

594

1.62

4.87

1.7

—

(3015183) Erythrocyte sedimentation rate

487

1.69

4.87

1.2

1.1

—

(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay

141

953

1.49

4.84

1.1

94.9

97.1

0.50

132

894

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

120

789

1.53

4.71

2.6

1.9

mg/l

24.3

24.9

0.04

209

(21494434) Karyotype in Bone marrow

523

1.65

4.69

1.2

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

411

1.73

4.64

1.2

—

(4306422)

187

1345

1.40

4.62

1.2

—

(3027570) Oxalate [Moles/time] in 24 hour Urine

3.34

4.59

1.0

1.5

umol/24h

357.1

338.5

0.12

(3042585) Pyridoxine [Moles/volume] in Serum or Plasma

179

2.13

4.57

1.2

1.3

nmol/l

122.6

118.5

0.05

130

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

160

2.19

4.54

1.0

1.1

—

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

424

1.70

4.45

1.2

—

(3035999) Lactate [Moles/volume] in Cerebral spinal fluid

625

1.57

4.43

1.3

mmol/l

2.0

0.03

586

(3024928) Oxygen saturation in Venous blood

206

1518

1.36

4.41

4.1

3.5

—

(3022493) Free Hemoglobin [Mass/volume] in Plasma

300

1.84

4.40

5.5

6.0

mg/l

4045.2

1409.8

0.28

210

(3006245) CD3-CD19+ cells/100 cells in Blood

272

1.88

4.38

1.9

2.2

13.4

9.9

1.43

260

(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum

178

1283

1.39

4.37

1.1

au/ml

9.7

10.6

—

(3014051) Protein [Presence] in Urine by Test strip

223

1668

1.34

4.35

2.3

2.0

—

(3035933) Granulocytes/100 leukocytes in Blood

254

1.89

4.23

1.5

1.6

—

(3012516) Albumin [Mass/volume] in Urine

2280

21066

1.10

4.19

3.4

3.3

mg/l

566.0

363.3

1.04

1511

13442

(3000093) Morphology [Interpretation] in Blood Narrative

595

1.57

4.17

1.1

—

(3023091) Interleukin 6 [Mass/volume] in Serum or Plasma

121

2.32

4.16

1.5

1.2

ng/l

33.6

86.8

1.21

(3019977) pH of Arterial blood

328

1.77

4.15

2.8

2.3

7.4

0.16

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

358

1.74

4.13

1.2

1.3

—

(3008295) Osmolality of Serum or Plasma

106

703

1.51

4.06

1.4

1.5

mosm/kgh2o

279.1

282.5

0.74

552

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

195

2.00

4.05

1.2

1.1

—

(3013201) Beta-2-Microglobulin [Mass/volume] in Serum or Plasma

482

1.62

4.05

1.6

1.9

mg/l

3.8

0.04

464

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

640

1.54

4.03

1.2

1.1

—

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

173

1260

1.38

4.02

1.2

—

(3027456) Digoxin [Moles/volume] in Serum or Plasma

125

859

1.46

4.02

2.8

3.0

nmol/l

0.8

0.20

636

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

394

3210

1.24

3.97

1.7

—

(3011985) Renin [Units/volume] in Plasma

149

1061

1.41

3.96

1.6

mu/l

65.9

62.6

0.09

130

959

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

3.02

3.95

1.9

1.3

—

(21491868) Cryoglobulin [Mass/volume] in Serum

212

1.94

3.89

1.2

1.1

g/l

—

0.3

—

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

297

3721

0.79

3.81

1.5

mg/l

3.4

3.3

0.15

206

2513

(3009508) Creatinine [Moles/volume] in Urine

2578

24061

1.09

3.79

3.2

mmol/l

8.1

8.2

0.42

2205

20521

(3012215) Mononuclear cells/100 leukocytes in Synovial fluid

120

2.25

3.79

1.4

1.2

44.2

39.4

0.26

(36204286) Streptococcus pneumoniae Danish serotype 5 IgG Ab [Mass/volume] in Serum

3.18

3.77

1.6

1.5

mg/l

3.4

2.6

—

(36203922) Streptococcus pneumoniae Danish serotype 14 IgG Ab [Mass/volume] in Serum

3.18

3.77

1.6

1.5

mg/l

2.0

4.3

—

(3023323) Follitropin [Units/volume] in Serum or Plasma

584

4977

1.18

3.71

1.4

iu/l

26.9

26.3

0.19

508

4272

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

106

720

1.48

3.65

1.7

1.6

—

(3025018) Bordetella pertussis Ab [Titer] in Serum

466

1.59

3.60

1.2

—

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

1016

9045

1.14

3.59

7.8

5.6

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

181

1355

1.34

3.58

1.1

—

(3010838) Calcium [Moles/time] in 24 hour Urine

339

1.69

3.48

1.6

mmol/24h

4.5

6.3

—

(3006270) Folate [Moles/volume] in Blood

622

1.50

3.48

1.2

1.1

nmol/l

383.5

381.6

0.03

549

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

2.37

3.47

1.1

—

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

179

1.96

3.47

1.2

1.1

—

(3003694) ABO and Rh group [Type] in Blood

2717

25518

1.09

3.42

1.6

1.5

—

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

601

1.50

3.40

2.3

2.7

—

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

153

2.03

3.39

1.1

1.2

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

586

1.51

3.37

1.0

—

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

188

1.92

3.37

1.1

—

(3006576) Bicarbonate [Moles/volume] in Blood

253

1.78

3.35

5.3

6.6

mmol/l

24.1

24.9

0.57

238

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

228

1787

1.28

3.27

1.3

mmol/l

3.7

0.05

213

1689

(4034850)

310

2522

1.24

3.24

10.3

7.6

—

(3014271) Vancomycin [Susceptibility]

264

1.75

3.21

2.8

2.7

—

(3001820) Epstein Barr virus nuclear Ab [Presence] in Serum

3.57

3.19

1.0

1.1

—

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

257

2054

1.26

3.16

1.3

mg/l

517.5

506.6

0.12

246

1957

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

193

1.87

3.14

1.1

—

(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma

252

1.75

3.11

1.2

g/l

0.3

0.48

198

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

366

1.62

3.10

1.8

1.6

u/field

1.6

3.1

1.37

273

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

194

1.86

3.09

1.1

—

(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy

3.08

1.2

1.0

—

(3020682) Albumin/Creatinine [Ratio] in Urine

2364

22162

1.09

3.08

4.2

4.0

mg/mmol

9.3

9.2

0.04

1555

14289

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

119

2.10

3.03

1.1

—

(3013637) Mi-2 Ab [Presence] in Serum

119

2.10

3.03

1.1

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

119

2.10

3.03

1.1

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

119

2.10

3.03

1.1

—

(3035637) Corticotropin [Mass/volume] in Plasma

133

979

1.36

3.00

1.6

—

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

293

1.68

2.98

1.1

—

(3024263) Appearance of Synovial fluid

263

1.71

2.98

1.7

1.3

—

(3030313) Adrenal Ab [Titer] in Serum

2.35

2.97

1.1

—

(40757373) Influenza virus identified in Isolate

2.24

2.95

1.3

1.2

—

(3045142) Bone marrow Pathology biopsy report

679

1.43

2.94

1.2

1.3

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

1389

12743

1.10

2.92

2.1

2.0

—

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

2286

21452

1.08

2.89

1.7

1.6

mmol/l

1.4

0.68

1945

18330

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

501

1.50

2.89

1.1

iu/ml

5.6

8.4

0.77

134

(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum

2.69

2.88

1.0

1.1

—

(3035320) C reactive protein [Mass/volume] in Body fluid

536

1.48

2.83

2.4

2.1

—

(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing

174

0.29

2.81

1.0

1.2

—

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

598

5235

1.15

2.77

3.3

3.4

pmol/l

4.5

4.6

1.71

531

4684

(3025130) Human papilloma virus identified in Specimen

168

1298

1.30

2.76

2.0

1.7

—

(3041354) Potassium [Moles/volume] in Venous blood

107

773

1.39

2.74

2.7

2.0

mmol/l

4.0

0.44

107

765

(3035285) Chloride [Moles/volume] in Venous blood

107

773

1.39

2.74

2.7

2.0

mmol/l

105.9

105.4

0.40

107

765

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

255

1.69

2.73

1.0

1.1

—

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

421

1.52

2.67

1.1

—

(4198724)

612

0.59

2.67

1.4

2.9

—

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

1393

12841

1.10

2.66

1.7

1.8

1.4

0.00

1222

11495

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

1518

14067

1.09

2.58

2.2

2.1

—

(1761868) Lipid panel - Serum or Plasma

3302

34538

0.94

2.55

2.5

2.6

—

(3021691) Plasmodium malariae Ab [Titer] in Serum

7.14

2.55

2.4

3.0

—

(3017446) Testosterone [Moles/volume] in Serum or Plasma

832

7486

1.12

2.54

2.3

2.2

nmol/l

13.1

0.00

761

6726

(3022475) Manganese [Moles/volume] in Blood

2.60

2.52

1.2

1.3

—

(3023659) Complement C1 esterase inhibitor.functional/Complement C1 esterase inhibitor.total in Serum or Plasma

231

1.69

2.51

1.2

106.9

109.9

0.43

206

(3030136) 5-Hydroxyindoleacetate [Moles/volume] in Serum or Plasma

501

1.46

2.51

2.7

3.3

nmol/l

157.4

107.3

0.35

496

(3000330) Specific gravity of Urine by Test strip

414

3558

1.17

2.49

3.6

2.9

—

(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay

2.82

2.47

1.2

1.1

—

(3002621) Streptococcal DNAse B [Units/volume] in Serum

2.38

2.45

1.0

1.1

—

(3027974) Hepatitis B virus e Ag [Presence] in Serum

2.67

2.44

1.5

1.4

—

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

2.24

2.43

1.1

—

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

129

981

1.32

2.42

1.2

1.3

—

(3033705) Calcium.ionized [Moles/volume] in Venous blood

103

758

1.36

2.40

2.7

2.0

—

(46236344) Yersinia enterocolitica O:9 IgG Ab [Presence] in Serum by Agglutination

5.00

2.40

1.0

—

(3033093) Yersinia sp IgM Ab [Titer] in Serum

5.00

2.40

2.0

—

(3038714) Yersinia pseudotuberculosis Ab [Titer] in Serum by Agglutination

5.00

2.40

1.0

—

(3039817) Yersinia enterocolitica IgA Ab [Presence] in Serum

5.00

2.40

2.0

—

(3042341) Yersinia pseudotuberculosis Ab [Presence] in Serum

5.00

2.40

2.0

—

(3040944) Yersinia pseudotuberculosis 3 Ab [Titer] in Serum

5.00

2.40

1.0

—

(3027923) C peptide [Moles/volume] in Serum or Plasma

433

1.48

2.38

1.5

1.6

nmol/l

1.2

1.3

0.13

339

(3008536) Aspergillus sp Ab [Presence] in Serum

2.11

2.38

1.8

3.0

—

(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum

2.75

2.37

1.1

—

(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method

2.42

2.36

2.3

6.2

—

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

369

1.52

2.36

1.9

1.8

umol/l

95.2

131.6

0.81

179

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

2.09

2.32

1.2

1.1

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

199

1.71

2.30

2.5

2.1

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

199

1.71

2.30

2.5

2.1

—

(3041082) Glomerular basement membrane Ab [Titer] in Serum by Immunofluorescence

2.86

2.30

1.1

—

(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay

412

1.48

2.30

2.0

1.8

143.8

134.5

0.38

389

(40765089) Chromosome analysis panel - Blood by G-banded

422

0.54

2.29

1.0

—

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

129

990

1.31

2.29

1.4

pmol/l

294.5

292.3

0.03

106

766

(3018840) Calcitonin [Moles/volume] in Serum or Plasma

2.37

2.29

1.7

2.8

pmol/l

3870.4

76.8

—

(3025443) Phadiatop IgE Ab [Units/volume] in Serum

348

1.53

2.28

1.1

u/ml

14.6

8.5

—

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

105

1395

0.75

2.28

1.4

1.3

mmol/l

6.7

7.1

0.61

1019

(3040668) CNBP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

3.48

2.26

1.0

—

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

2.55

2.26

1.1

1.0

—

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

141

1097

1.29

2.26

1.2

1.3

nmol/l

0.3

—

(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood

422

1.47

2.25

1.8

2.8

34.6

39.4

0.58

148

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

127

1.89

2.25

1.0

1.1

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

270

1.59

2.24

1.4

1.5

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

270

1.59

2.24

1.4

1.5

—

(3048879) Bone marrow aspiration report

156

1.80

2.24

1.9

2.4

—

(3012494) Peanut IgE Ab [Units/volume] in Serum

239

1.63

2.24

1.0

1.1

u/ml

0.2

6.8

1.24

139

(3016750) Collection duration of Urine

391

1.49

2.22

2.6

2.0

min

510.5

502.8

0.22

313

(3016135) IgD [Mass/volume] in Serum

5.56

2.21

1.0

mg/l

43.2

69.4

—

(3026179) Normetanephrine [Moles/volume] in Serum or Plasma

140

1093

1.28

2.20

1.2

1.3

nmol/l

0.6

3.1

1.09

133

1057

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

417

1.47

2.18

1.8

1.6

—

(3034426) Prothrombin time (PT)

288

1.56

2.18

1.4

1.2

—

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

488

4293

1.14

2.18

2.4

2.3

u/l

5809.9

5916.3

0.02

170

1736

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

143

1.82

2.18

1.1

—

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

273

1.58

2.16

2.3

2.4

—

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

125

965

1.30

2.15

1.1

1.3

nmol/l

—

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

436

1.45

2.13

1.1

—

(40768800) Prostate Pathology biopsy report

107

1401

0.76

2.12

1.3

1.2

—

(3009214) Lutropin [Units/volume] in Serum or Plasma

373

3231

1.16

2.08

1.4

u/l

8.5

8.6

0.11

311

2659

(3003129) Base excess in Capillary blood by calculation

138

1.81

2.08

1.7

mmol/l

-0.6

0.7

0.65

128

(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture

0.00

2.06

0.0

1.1

—

(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation

274

2319

1.19

2.04

2.0

1.9

pmol/l

206.9

200.5

0.44

263

2203

(3022229) Phosphate [Moles/volume] in Urine

2.40

2.02

2.1

2.2

mmol/l

22.1

19.5

0.25

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

143

1136

1.26

1.99

1.2

u/l

29.6

30.0

0.02

130

979

(3036603) Volume of Urine

460

1.42

1.97

1.7

1649.9

2097.3

—

(3017937) Magnesium [Moles/time] in 24 hour Urine

3.33

1.96

1.7

1.2

—

(4024509)

648

1.35

1.95

1.3

1.5

—

(3007919) Fasciola sp Ab [Titer] in Serum

4.55

1.94

1.0

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

214

1781

1.21

1.94

1.2

1.3

—

(3001850) Coagulation factor XI activity actual/normal in Platelet poor plasma by Coagulation assay

187

1.66

1.93

1.1

74.7

88.2

—

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

437

1.42

1.93

1.1

nmol/l

0.6

8.0

0.88

(3028772) Osteocalcin [Mass/volume] in Serum or Plasma

547

1.37

1.92

2.4

3.2

—

30.7

—

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

150

1.74

1.90

1.0

1.1

—

(3036670) Protein [Mass/volume] in Synovial fluid

128

1.80

1.89

1.3

1.2

g/l

38.3

39.0

0.10

(3051659) 25-hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

2.08

1.86

1.3

1.1

nmol/l

15.0

15.9

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

174

1.67

1.85

1.0

1.1

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

174

1.67

1.85

1.0

1.1

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

174

1.67

1.85

1.0

1.1

—

(3036180) Methadone [Presence] in Urine

3.04

1.79

1.0

2.9

—

(3046861) Legionella sp Ag [Presence] in Urine

3.04

1.79

1.4

1.0

—

(40761995) Spermatozoa Progressive [#/volume] in Semen

426

0.61

1.78

4.2

3.3

—

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

445

1.40

1.77

1.6

1.9

—

(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen

425

0.61

1.76

8.5

6.6

—

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

280

1.50

1.75

1.1

94.1

93.0

0.07

126

(40763480) Human metapneumovirus Ag [Presence] in Specimen

2.67

1.72

1.1

1.4

—

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

282

1.49

1.70

1.0

1.1

—

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

218

1843

1.19

1.70

1.4

e6/l

78.2

22.2

0.52

166

1398

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

218

1843

1.19

1.70

1.5

1.4

e6/l

745.5

3292.5

0.66

175

1479

(3013945) Hepatitis B virus e Ab [Presence] in Serum

2.29

1.70

1.5

1.4

—

(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid

2.29

1.70

1.0

1.1

—

(3040151) Glucose [Moles/volume] in Capillary blood

769

1.29

1.69

6.2

14.7

mmol/l

7.1

7.3

0.14

640

(3044290) Cell count panel - Cerebral spinal fluid

205

1726

1.19

1.68

1.5

1.4

—

(3023709) Somatotropin [Mass/volume] in Serum or Plasma

316

1.46

1.67

2.1

2.7

ug/l

1.3

1.2

0.25

294

(3010937) Rubella virus Ab [Presence] in Serum

2.10

1.65

1.0

1.1

—

(3033306) Mononuclear cells/100 leukocytes in Cerebral spinal fluid

435

1.38

1.64

1.3

39.8

66.9

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

599

1.32

1.62

1.1

—

(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay

394

1.40

1.61

1.1

1.0

99.3

96.2

0.27

321

(3017312) HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

2.50

1.59

1.3

1.1

—

(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay

190

1.58

1.59

1.1

73.8

84.1

—

(40768795) Lymph node Pathology biopsy report

726

1.28

1.56

1.2

—

(3002619) Bacteria identified in Specimen by Culture

137

1.68

1.54

1.3

1.1

—

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

107

1.78

1.54

1.2

—

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

289

1.46

1.54

1.1

97.3

92.8

0.56

126

(3020874) Milk IgE Ab [Units/volume] in Serum

606

1.31

1.51

1.0

1.1

u/ml

4.2

0.7

0.62

155

(3025886) Oxalate [Mass/time] in 24 hour Urine

2.59

1.51

1.6

1.1

—

(21494755) Public health laboratory ask at order entry panel

1116

11899

0.93

1.51

1.3

—

(3033086) Enterovirus NOS Ab [Titer] in Serum

2.86

1.50

1.0

—

(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood

101

1.78

1.48

1.7

1.9

—

(3011335) Digoxin [Mass/volume] in Serum or Plasma

2.43

1.47

2.7

2.4

—

(3029612) Listeria sp Ab [Titer] in Serum

2.73

1.43

1.2

1.3

—

(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method

2.04

1.43

1.1

—

(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma

379

3388

1.12

1.42

1.8

nmol/l

39.0

39.3

0.07

374

3308

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

237

1.48

1.41

1.2

1.1

—

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

304

1.42

1.39

1.1

—

(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method

2.61

1.36

2.3

3.0

—

(3004446) Plasmodium sp identified in Blood by Light microscopy

1.83

1.35

2.3

2.7

—

(1002224) Polysomnography panel

462

4195

1.11

1.32

1.1

—

(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma

208

0.53

1.32

1.5

1.2

—

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

8169

82588

0.95

1.31

3.7

3.6

mmol/l

1.3

3.67

7630

77051

(3016018) Differential panel - Cerebral spinal fluid

112

918

1.22

1.29

1.6

1.4

—

(44813793)

570

1.28

1.27

1.0

1.1

—

(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid

2.00

1.27

1.0

1.1

—

(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

2.05

1.26

1.2

1.0

—

(3050129) First trimester maternal screen panel - Serum or Plasma

341

3799

0.89

1.26

1.5

1.4

—

(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay

294

1.40

1.25

1.2

1.1

115.3

108.3

0.50

265

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

146

1.58

1.25

1.1

1.5

—

(3017569) Oxygen content in Arterial blood

244

1.44

1.25

3.0

2.3

—

(3009466) Valproate [Moles/volume] in Serum or Plasma

114

1375

0.83

1.23

4.7

5.5

umol/l

348.9

370.1

0.83

1199

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

1.86

1.23

1.1

—

(3003721) Smooth muscle Ab [Units/volume] in Serum

2.00

1.23

1.0

1.1

—

1.3

—

(3014702) Chromogranin A [Moles/volume] in Serum or Plasma

107

879

1.22

3.2

3.3

nmol/l

10.0

10.8

0.04

102

854

(3028707) Methadone [Presence] in Urine by Screen method

191

2202

0.86

1.21

1.8

3.2

—

(44806420)

188

0.53

1.20

2.4

2.2

—

(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection

2.31

1.18

1.8

1.2

—

(40765096) Chromosome analysis panel by Banding

189

1.48

1.18

1.3

1.1

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

271

3045

0.89

1.18

1.4

—

(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright

173

1.50

1.17

1.2

pmol/l

217.1

282.3

0.75

132

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

270

3033

0.89

1.17

1.4

—

(3020951) Lymphocytes/100 leukocytes in Cerebral spinal fluid

1.70

1.17

1.1

1.4

51.3

58.9

—

(3000012) Reticulocyte production index

333

1.35

1.16

1.5

1.4

—

(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay

153

0.52

1.13

2.3

2.6

—

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

1.69

1.13

1.1

—

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

272

3046

0.89

1.13

1.4

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

270

3024

0.89

1.12

1.4

—

(4281824)

799

0.79

1.11

1.2

—

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

192

1.46

1.11

8.2

7.1

—

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

152

1.51

1.08

1.0

1.1

—

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

1.65

1.06

1.1

—

(4094501)

241

2143

1.13

1.06

1.1

—

(3047189) Immunofixation for 24 hour Urine

270

1.37

1.06

1.5

1.7

—

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

374

3409

1.10

1.05

1.3

miu/ml

233.7

229.8

0.07

157

1636

(3013336) Amino acids [Identifier] in Serum or Plasma

2.27

1.03

3.0

2.9

—

(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection

2.06

1.02

8.1

6.0

—

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

217

1924

1.13

1.01

1.1

u/ml

1.7

1.5

0.11

758

(4211845)

403

1.29

1.01

2.7

2.5

—

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

8652

87217

0.96

1.01

4.4

4.3

mmol/l

2.8

2.9

16.88

8095

81514

(3043870) Heparin induced platelet Ab [Units/volume] in Serum

1.89

1.01

1.5

1.3

—

(3019779) Phenytoin [Moles/volume] in Serum or Plasma

106

0.47

1.00

2.0

3.3

umol/l

19.5

40.4

—

(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum

1.88

1.00

1.1

1.2

—

(3014133) Dog dander IgE Ab [Units/volume] in Serum

162

1410

1.15

1.00

1.1

u/ml

2.4

3.8

1.02

531

(3010726) Horse dander IgE Ab [Units/volume] in Serum

186

1637

1.14

0.98

1.1

u/ml

2.8

2.0

0.29

378

(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis

1.85

0.96

1.1

1.2

—

(3008401) Mugwort IgE Ab [Units/volume] in Serum

189

1668

1.14

0.96

1.1

u/ml

0.9

1.1

0.39

686

(3037556) Urate [Mass/volume] in Serum or Plasma

190

1.42

0.96

1.2

1.3

—

(3005532) Lymphocytes/100 leukocytes in Pleural fluid

207

1.40

0.96

1.3

1.4

40.8

66.6

3.39

172

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

267

1.35

0.95

1.1

1.2

—

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

8486

85551

0.96

0.95

4.0

3.9

mmol/l

1.4

0.06

7970

80194

(3014599) Egg white IgE Ab [Units/volume] in Serum

613

1.23

0.95

1.0

1.1

u/ml

0.9

1.9

0.58

135

(3000764) Benzodiazepines [Presence] in Urine

491

5287

0.93

0.95

1.6

2.2

—

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

186

1642

1.14

0.95

1.5

nmol/l

0.4

0.21

150

1312

(43055514) Macroprolactin [Presence] in Serum or Plasma

282

0.67

0.94

1.3

1.4

—

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

524

1.24

0.94

2.5

1.9

u/field

2.1

2.0

0.06

228

(3021162) Amylase [Enzymatic activity/volume] in Specimen

133

1.50

0.94

3.2

u/l

566.6

1207.9

0.62

122

(3006462) Nitrate [Presence] in Urine

364

1.29

0.93

2.5

2.6

—

(3003888) Timothy IgE Ab [Units/volume] in Serum

196

1738

1.13

0.93

1.1

u/ml

7.7

6.2

0.48

900

(3026692) Albumin [Mass/volume] in Peritoneal fluid

175

1.43

0.92

1.2

1.4

g/l

11.5

12.9

0.26

128

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

1385

14430

0.95

0.92

2.7

ug/l

0.7

0.45

863

8727

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

1.82

0.92

1.1

—

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

296

3252

0.91

1.5

—

(3007625) Streptococcus pneumoniae Ag [Presence] in Specimen

2.14

0.91

1.2

1.5

—

(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

134

1.49

0.91

11.5

5.3

—

(3004775) Volume in Urine collected for unspecified duration

554

1.23

0.90

2.4

2.2

779.8

631.8

1.46

396

(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid

108

920

1.18

0.90

1.1

—

14.8

—

(43533860) Galactose-alpha-1,3-galactose (Alpha-Gal) IgE Ab [Units/volume] in Serum

1.60

0.90

1.0

1.1

u/ml

0.0

0.3

—

(3042517) Benzodiazepines panel - Urine

151

1.46

0.90

1.8

2.8

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

228

2535

0.90

0.89

1.5

—

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

519

1.23

0.89

5.1

7.0

—

(3005033) Fetal Nuchal fold Thickness US

222

2470

0.90

0.88

1.4

—

(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma

1.79

0.87

1.1

1.0

u/l

33.4

9.2

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

584

0.79

0.87

1.9

1.6

—

(3044242) Glucose [Moles/volume] in Arterial blood

289

1.32

0.87

3.0

2.2

—

(3001893) Eosinophils/100 leukocytes in Pleural fluid

169

1.42

0.87

1.3

1.4

4.6

3.7

0.15

147

(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma

2.00

0.87

1.0

1.1

—

(3027944) Amphetamines [Presence] in Urine

490

5253

0.93

0.86

1.5

2.1

—

(3028300) Cannabinoids [Presence] in Urine

498

5335

0.93

0.86

1.6

2.2

—

(3027300) Silver Birch IgE Ab [Units/volume] in Serum

281

1.32

0.86

1.1

1.0

u/ml

14.8

11.2

—

(3027008) Opiates [Presence] in Urine

497

5324

0.93

0.86

1.5

2.1

—

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

7740

76673

1.03

0.85

5.2

5.0

mmol/mol

38.7

39.0

2.93

7262

71797

(3004905) Lipase [Enzymatic activity/volume] in Serum or Plasma

153

1.44

0.85

2.9

5.3

u/l

76.9

62.7

—

(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay

1.94

0.84

1.3

1.4

—

(3020123) Porphyrins [Interpretation] in Serum or Plasma

1.78

0.84

1.0

1.1

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

224

2478

0.90

0.82

1.4

—

(3023511) Choriogonadotropin [Units/volume] in Urine

237

2146

1.11

0.82

1.5

1.3

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

146

1286

1.14

0.81

1.2

1.3

—

(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma

172

1.40

0.80

1.5

1.7

—

(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal

683

1.19

0.79

1.3

nmol/l

1.4

0.13

601

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

313

2879

1.09

0.79

1.7

1.8

—

(3023430) Cat dander IgE Ab [Units/volume] in Serum

149

1318

1.13

0.78

1.1

u/ml

6.8

4.9

0.43

520

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

131

1.45

0.78

1.0

—

(3051101) Glucose [Moles/volume] in Cord blood

122

0.57

0.77

6.1

6.3

—

(3009471) Fatty acids.nonesterified [Moles/volume] in Serum or Plasma

0.00

0.77

0.0

6.2

—

0.2

—

(3016879) Cocaine [Presence] in Urine

460

4909

0.93

0.75

1.6

2.3

—

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

146

1295

1.13

0.74

1.4

1.6

—

(3032390) JC virus DNA [#/volume] (viral load) in Urine by NAA with probe detection

2.00

0.72

5.0

3.0

—

(3032333) Phosphate [Mass or Moles] in 24 hour Urine

2.00

0.72

1.2

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

201

1820

1.11

0.72

1.8

1.7

—

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

132

1167

1.13

0.71

1.0

u/ml

0.3

0.06

221

(3030862) Granulocytes [#/volume] in Cerebral spinal fluid

264

1.29

0.71

1.1

1.2

39.6

18.1

—

(4212803)

1.58

0.71

1.1

1.0

—

(3003752) BK virus DNA [Units/volume] (viral load) in Urine by NAA with probe detection

1.92

0.70

5.0

2.9

—

(3035880) pH of Pleural fluid

300

1.27

0.70

1.3

—

(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain

158

0.63

0.70

1.1

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

378

4046

0.93

0.68

1.6

2.4

—

(3002331) Protein [Mass/volume] in Peritoneal fluid

152

1.38

0.68

1.0

1.5

g/l

24.3

25.0

0.07

116

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

122

1379

0.88

0.68

1.2

—

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

1.85

0.68

1.2

1.0

—

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.56

0.68

1.1

—

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

953

9149

1.05

0.66

4.0

32.4

31.5

1.58

720

6408

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

151

1356

1.12

0.65

1.4

1.5

—

(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine

1.59

0.65

1.6

2.1

—

(3039443) Prostate specific Ag panel - Serum or Plasma

165

1824

0.90

0.64

1.5

1.6

—

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

729

1.15

0.62

1.0

1.1

mg/l

269.6

257.6

0.12

656

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

281

1.25

0.59

2.5

2.1

—

(3011288) Drugs identified in Urine by Screen method

328

3502

0.93

0.58

2.2

3.3

—

(3028308) Erythrocytes [#/volume] in Pleural fluid

606

0.84

0.58

1.4

e6/l

13126.7

60903.5

2.45

359

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

175

1.31

0.58

1.1

—

(3042010) Triglyceride [Moles/volume] in Pleural fluid

1.46

0.57

1.2

1.3

mmol/l

0.7

2.0

—

(3045716) Anion gap in Serum or Plasma

282

1.24

0.57

3.2

2.6

mmol/l

8.4

9.4

0.88

206

(40771901) t(9;22)(q34.1;q11)(ABL1,BCR) b2a2+b3a2 fusion transcript/control transcript (International Scale) [# Ratio] in Blood or Tissue by Molecular genetics method

1.71

0.57

9.3

9.5

—

(3009677) Dengue virus Ab [Presence] in Serum

1.67

0.56

1.0

1.2

—

(40760435) Tropomyosin IgE Ab [Units/volume] in Serum

1.43

0.56

1.0

—

(40757494) Bilirubin.total [Moles/volume] in Blood

393

1.20

0.55

2.0

2.5

umol/l

16.3

40.0

—

(3016913) Creatine kinase.MM [Enzymatic activity/volume] in Serum or Plasma by Electrophoresis

1.62

0.55

1.2

1.0

u/l

228.8

517.3

—

(3027401) Testosterone Free/Testosterone.total in Serum or Plasma

1.58

0.54

1.2

1.4

1.3

—

(44806071)

1.41

0.54

1.2

1.1

—

(3041806) Other cells [#/volume] in Blood by Manual count

450

1.18

0.53

1.5

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

155

1697

0.91

0.53

4.5

3.0

mg/l

22.5

26.7

1.02

1064

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

750

1.13

0.52

1.1

mg/l

41.8

42.5

0.05

636

(3020356) Listeria sp identified in Specimen by Organism specific culture

1.52

0.52

1.2

1.1

—

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

684

0.86

0.52

1.2

1.5

—

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

140

1537

0.91

0.51

1.2

1.3

ug/l

2.5

3.8

3.33

130

1385

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

648

1.14

0.51

1.3

1.9

—

(4027681)

583

1.15

0.51

1.2

—

(40761872) Peanut recombinant (rAra h) 2 IgE Ab [Units/volume] in Serum

144

1.32

0.50

1.1

u/ml

0.1

8.5

1.36

102

(3001556) Androgen free Index in Serum or Plasma

144

1.32

0.50

1.8

1.3

—

(40758292) HTLV I+II Ab panel - Serum

144

1.32

0.50

1.4

—

(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma

162

1.30

0.49

1.1

1.2

—

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

1936

19781

0.97

0.49

3.9

3.8

21.2

21.9

0.96

845

8529

(3020650) Glucose [Presence] in Urine

234

1.24

0.49

1.4

—

(3019768) Coxiella burnetii Ab [Presence] in Serum

1.56

0.48

1.0

—

(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid

1.56

0.48

1.0

—

(3032868) Hemoglobin electrophoresis panel in Blood

109

0.64

0.48

1.1

1.5

—

(3032743) Legionella sp IgG Ab [Presence] in Serum

1.52

0.48

1.1

—

(3019174) dRVVT (LA screen)

1.45

0.48

1.0

1.2

—

(21494567) Legionella sp IgM Ab [Presence] in Serum

1.49

0.47

1.1

—

(3003633) Ovomucoid IgE Ab [Units/volume] in Serum

1.49

0.47

1.1

1.3

u/ml

1.2

1.8

—

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

102

1.37

0.47

1.2

1.4

—

(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal

815

1.12

0.46

1.3

mmol/l

10.8

11.7

0.48

180

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

117

0.68

0.45

1.0

1.1

—

(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid

319

1.19

0.45

1.1

ng/l

150.7

300.5

—

(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification

493

0.85

0.45

5.4

7.1

u/ml

33.0

5850.4

—

120

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

163

0.74

0.43

1.0

1.1

—

(3033799) Differential panel - Peritoneal fluid

220

1.23

0.43

1.8

2.0

—

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.41

0.43

1.2

1.1

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

643

6201

1.04

0.42

1.9

—

(37019676) Renin [Units/volume] in Plasma --supine

0.00

0.41

0.0

1.3

—

18.6

—

(3035060) Mercury [Moles/volume] in Blood

0.00

0.41

0.0

2.0

—

7.3

—

(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose

836

0.90

0.40

1.5

1.6

mmol/l

7.3

7.6

0.58

508

(1617658) Protocol used for examination of sentinel lymph nodes

593

0.88

0.40

1.0

1.1

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

548

5689

0.96

0.40

1.5

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

322

3063

1.05

0.39

1.5

—

(3050794) Legionella sp Ab [Presence] in Serum

1.31

0.39

1.1

—

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

826

1.10

0.39

3.9

5.0

u/ml

47.2

68.3

0.39

251

(3020491) Glucose [Moles/volume] in Blood

636

1.12

0.38

2.0

1.9

mmol/l

7.2

6.4

1.61

467

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

2516

24780

1.02

0.38

4.4

4.3

ug/l

2.5

2.7

0.14

2280

22496

(3018980) carBAMazepine [Moles/volume] in Serum or Plasma

291

0.82

0.38

1.9

3.0

umol/l

25.8

28.1

0.47

208

(3023410) Appearance of Cerebral spinal fluid

866

1.10

0.38

1.7

1.6

—

(3014891) Appearance of Pleural fluid

1.32

0.37

1.9

1.5

—

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

190

1784

1.07

0.37

2.5

2.3

ug/min

66.1

115.6

1.29

106

1135

(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum

125

1.28

0.36

1.0

—

(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose

116

0.69

0.36

1.4

1.2

—

(1761482) Bacteria [#/volume] in Urine by Culture

182

1710

1.07

0.35

4.5

3.5

—

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

137

1471

0.93

0.35

1.1

iu/ml

30.8

7615.6

0.64

355

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

122

0.74

0.35

1.0

—

(3018834) Bilirubin.total [Presence] in Urine by Test strip

1.40

0.35

2.5

3.3

—

0.0

—

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

1.37

0.34

1.2

1.3

—

(3044009) aPTT.lupus sensitive (LA screen)

1.37

0.34

1.0

1.2

—

(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk

283

1.17

0.34

1.0

—

(3033923) Metanephrine [Moles/time] in 24 hour Urine

145

1.24

0.33

1.3

1.1

umol/24h

0.6

0.7

—

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

782

0.91

0.33

1.5

—

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

701

1.10

0.33

1.1

1.0

—

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

837

1.09

0.32

1.1

1.0

—

(3015076) Soybean IgE Ab [Units/volume] in Serum

581

1.10

0.30

1.0

u/ml

0.4

1.6

—

(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis

1.29

0.30

8.5

8.2

mmol/l

4.1

6.1

2.33

(40768806) Pleura Pathology biopsy report

588

0.90

0.29

1.4

1.5

—

(4133840)

281

0.85

0.28

1.3

1.2

—

(3019832) Treponema pallidum Ab [Presence] in Serum

1163

11410

1.02

0.28

1.8

1.7

—

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

383

1.12

0.28

1.6

1.9

—

(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma

795

1.08

0.28

2.0

2.3

nmol/l

19.8

19.5

0.13

758

(3005011) Chlamydia sp Ab [Titer] in Serum

103

1.26

0.28

1.8

1.5

—

(3022689) Creatine [Moles/volume] in Urine

248

0.85

0.28

2.1

1.4

—

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

1.23

0.27

2.0

2.1

—

(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline

510

0.90

0.26

1.4

mmol/l

5.4

5.6

0.47

486

(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum

0.68

0.26

1.0

1.1

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

616

1.09

0.25

1.2

1.1

—

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

224

0.85

0.25

1.7

2.1

umol/l

20.8

16.5

0.67

224

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

1.20

0.25

3.9

2.1

u/field

0.1

0.6

—

(3015401) Amylase [Enzymatic activity/volume] in Pleural fluid

1.17

0.24

1.3

u/l

24.6

182.2

—

(3016273) Islet cell 512 Ab [Units/volume] in Serum

0.74

0.24

1.0

—

(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis

1.28

0.23

5.8

6.2

—

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

457

1.09

0.22

1.0

ng/l

317.2

320.6

0.03

328

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

8584

86067

0.99

0.22

4.1

4.0

mmol/l

4.6

4.7

13.42

8099

80978

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

212

2037

1.04

0.22

2.1

1.9

iu/l

3.7

4.3

0.71

773

(3051593) INR in Capillary blood by Coagulation assay

276

1.12

0.22

5.7

9.2

—

(42528783) Honey bee recombinant (rApi m) 10 IgE Ab [Units/volume] in Serum

0.00

0.21

0.0

1.0

—

(40759632) Porphyrins [Mass/mass] in Stool

0.00

0.21

0.0

1.1

—

(40762887) Creatinine [Moles/volume] in Blood

0.00

0.21

0.0

1.1

—

(3027859) Formaldehyde IgE Ab [Units/volume] in Serum

0.00

0.21

0.0

1.0

—

(3015147) Influenza virus A IgG Ab [Units/volume] in Serum

0.00

0.21

0.0

1.0

—

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

488

1.09

0.21

1.0

u/l

1.2

1.0

0.41

213

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

396

3854

1.03

0.21

2.0

1.9

—

(3008640) Bordetella pertussis IgG Ab [Titer] in Serum

0.00

0.21

0.0

1.0

—

(3023199) Leukocytes [#/volume] in Pleural fluid

667

0.93

0.20

1.4

e6/l

2815.7

2311.5

0.40

478

(3051596) Benzodiazepines [Presence] in Serum or Plasma by Screen method

0.00

0.20

0.0

1.1

—

(4038314)

114

0.79

0.20

1.2

—

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

635

6225

1.02

0.19

1.2

iu/ml

96.0

150.8

4.11

223

2442

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

1.23

0.18

1.8

1.9

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

153

1594

0.96

0.18

1.2

—

(3034092) Cytoplasmic Ig cells/100 cells in Blood

128

1.17

0.18

6.1

6.4

—

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

147

1.16

0.18

1.2

—

(3029634) Reagin Ab [Titer] in Serum by VDRL

150

1441

1.04

0.17

2.3

2.2

titre

13.0

8.1

—

(3002067) Lambda light chains [Mass/time] in 24 hour Urine

1.21

0.17

3.3

3.6

—

(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum

1.15

0.17

1.0

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

797

7846

1.02

0.17

2.1

2.0

—

(3041678) Intrinsic coagulation system thromboelastography panel - Blood

1.13

0.17

1.7

1.5

—

(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)

397

1.08

0.17

1.5

1.7

nmol/l

3.9

10.2

0.51

330

(3025315) Body weight

1.11

0.17

6.9

3.1

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

261

2685

0.97

0.17

1.5

—

(3001019) Free T4 and TSH panel - Serum or Plasma

577

5665

1.02

0.17

1.7

1.6

—

(43055246) Days in therapeutic INR range/Days INR result determined [Ratio]

129

1.16

0.17

5.3

6.9

60.8

71.8

—

106

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

514

1.07

0.16

1.5

1.3

—

(21491866) Provasopressin.C-terminal [Moles/volume] in Serum or Plasma by Immunoassay

1.10

0.15

1.1

1.6

pmol/l

5.3

13.6

—

(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis

297

0.91

0.15

1.3

1.5

pmol/l

15.2

14.4

0.45

246

(3000285) Sodium [Moles/volume] in Blood

0.75

0.15

1.0

1.1

—

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

8215

81970

1.01

0.15

4.1

4.0

mmol/l

5.8

1.01

7618

75944

(3029396) Erythrocyte agglutination [Presence] in Blood

303

1.09

0.15

3.2

3.0

—

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

459

1.07

0.14

1.0

ng/l

794.7

734.6

0.48

318

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

367

0.93

0.13

1.2

1.1

—

(3026470) Cobalt [Mass/volume] in Blood

363

1.07

0.13

1.9

2.0

ug/l

2.6

3.3

0.55

311

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

461

1.06

0.13

1.0

ng/l

36.9

43.5

0.60

327

(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid

151

1.13

0.13

1.3

1.2

ug/l

16.0

349.8

—

(3045781) Inhibin B [Mass/volume] in Serum or Plasma

209

1.10

0.13

1.3

2.5

ng/l

119.5

132.1

0.15

113

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

240

0.92

0.11

2.0

1.9

—

(3003434) Protein [Mass/volume] in Pleural fluid

739

1.04

0.11

1.4

g/l

33.4

34.1

0.17

666

(4146454)

720

0.96

0.11

2.7

2.8

—

(3020191) Ethanol [Moles/volume] in Serum or Plasma

819

1.04

0.10

1.8

1.5

promille

1.0

1.4

1.40

617

(3013139) Helicobacter pylori Ag [Presence] in Stool

544

5509

0.99

0.10

1.2

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

1017

10256

0.99

0.10

1.7

1.8

—

(3045788) Cell count panel - Pleural fluid

524

0.95

0.09

1.4

1.5

—

(3017509) Phencyclidine [Presence] in Urine

145

0.90

0.09

1.2

1.8

—

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

227

0.92

0.09

1.0

1.1

—

(40768793) Breast Pathology biopsy report

171

1747

0.98

0.09

1.4

1.3

—

(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma

126

1.11

0.09

1.9

1.5

ng/l

154.0

122.7

0.31

126

(3024869) Neuronal Ab [Presence] in Serum

126

1.11

0.09

1.1

—

(3021387) Prolactin [Units/volume] in Serum or Plasma

400

3948

1.01

0.09

1.6

1.7

mu/l

300.7

301.2

0.01

368

3570

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

248

2438

1.02

0.09

1.9

1.8

—

(3011048) Pyruvate [Moles/volume] in Blood

0.79

0.08

1.0

1.3

umol/l

82.2

85.9

—

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

152

1552

0.98

0.08

1.4

u/l

24.6

23.9

0.10

132

1281

(3034459) Mononuclear cells/100 leukocytes in Pleural fluid

1.04

0.08

1.4

74.3

73.5

—

(40766799) MGMT gene methylation score in Tissue by Molecular genetics method

1.03

0.07

1.0

—

(3045462) Protein/Creatinine [Ratio] in Urine

1.12

0.07

2.6

3.4

g/mol

23.2

52.4

1.23

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

184

0.92

0.07

1.3

—

(3043410) Blood group antigens tested for on Red Blood Cells

206

1.07

0.07

1.8

1.7

—

(3028717) Thiamine [Mass/volume] in Blood

0.86

0.06

1.1

1.2

—

(3038071) Oxygen [Partial pressure] in Mixed venous blood

177

1.07

0.06

9.2

7.3

—

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood

138

1.09

0.06

7.5

7.4

—

(3012441) Differential panel - Pleural fluid

564

1.03

0.05

1.4

—

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

413

4098

1.01

0.05

1.9

3.2

u/ml

42.0

45.6

0.11

399

3959

(3016628) Fibrinogen Ag [Mass/volume] in Platelet poor plasma by Immunoassay

130

1.08

0.04

1.1

1.2

mg/l

0.3

51.7

—

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

208

2057

1.01

0.04

1.5

—

(3044007) Cell count panel - Peritoneal fluid

209

1.05

0.04

1.9

2.0

—

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

220

1.05

0.03

1.7

1.9

e6/l

7977.6

15475.3

0.35

120

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

508

1.02

0.03

1.2

1.3

—

(3005411) Squamous cell carcinoma Ag [Mass/volume] in Serum or Plasma

161

1.06

0.03

1.1

1.7

ug/l

1.2

2.1

—

(3000034) Microalbumin [Mass/volume] in Urine

719

1.02

0.02

3.6

2.8

mg/l

41.2

67.2

0.53

530

(3016244) Insulin [Units/volume] in Serum or Plasma

590

0.98

0.02

2.8

3.5

mu/l

42.6

30.9

0.84

558

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

619

0.99

0.02

1.6

2.6

—

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

977

0.99

0.01

1.3

1.4

pmol/l

71.2

107.2

0.48

266

(3023487) Leukocytes [#/volume] in Peritoneal fluid

254

1.02

0.00

1.7

2.1

e6/l

741.5

1022.4

0.44

177

(43534046) Estradiol (E2) [Moles/volume] in Serum or Plasma by High sensitivity method

155

0.97

0.00

1.7

1.5

nmol/l

0.2

—

111

(3008116) Ketones [Moles/volume] in Urine by Test strip

185

0.97

0.00

1.6

1.4

—

(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration

372

0.99

0.00

2.2

2.1

ug/min

77.0

102.6

—

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

168

1685

1.00

0.00

2.0

2.2

nmol/l

0.9

0.8

1.69

141

1436

(3005593) Pancreatic islet cell Ab [Titer] in Serum

0.00

0.0

1.0

—

(3032995) BK virus DNA [#/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection

0.00

0.0

1.0

—

(42868452) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Bone marrow by Molecular genetics method

0.00

0.0

5.7

—

(3017986) Aspergillus versicolor IgE Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(3030940) RBC casts [#/area] in Urine by Computer assisted method

0.00

0.0

1.2

—

(3028917) Waxy casts [#/area] in Urine by Computer assisted method

0.00

0.0

1.2

—

(3007463) Buprenorphine [Presence] in Urine

0.88

0.00

2.0

5.6

—

(3018910) Alkaline phosphatase.bone [Mass/volume] in Serum or Plasma

0.00

0.0

1.0

—

(40760866) Procollagen type III.N-terminal propeptide [Units/volume] in Serum

0.00

0.0

1.0

—

(3002853) Influenza virus B Ab [Titer] in Serum

0.00

0.0

1.0

—

(3042552) Rheumatoid factor [Units/volume] in Pleural fluid

1.02

0.00

1.2

1.0

iu/ml

—

10.2

—

(40760512) CD34 cells/100 cells in Bone marrow

0.00

0.0

1.3

—

(3014064) Pregnancy associated plasma protein A [Multiple of the median] in Serum or Plasma

0.90

0.00

1.2

1.1

—

(3016816) Cytomegalovirus IgG Ab [Presence] in Serum or Plasma

0.00

0.0

1.0

—

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

0.95

0.00

1.0

1.1

—

(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method

0.95

0.00

1.0

1.1

—

Mortality – FinRegistry

↥

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

Relationships between endpoints

↥

Index endpoint: RX_A07EC02 – 5-aminosalicylic acid

GWS hits: -

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

≡ Risteys

FG R12 + FR

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

5-aminosalicylic acid

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

All original rules

Similar endpoints

Case counts by codes

Case counts by code for 5-aminosalicylic acid (RX_A07EC02)

Summary Statistics

-FinRegistry-

-FinnGen-

Key figures

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

Matched cohort

LabWAS

Mortality – FinRegistry

Relationships between endpoints